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 ABSTRACT 
 
Different substances were evaluated and compared to an antibiotic, in terms of their effect on nitrogen 
- and amino acid digestibilities. Two digestibility trials and one performance trial were conducted.  
 
Trials one and two apparent nitrogen (AND)- and amino acid (AAD) digestibilities were determined 
from digesta collected at the terminal ileum (ileal digestibility method). In Trial 3 the substances were 
evaluated in terms of their potential to improve production performance. Broilers were fed a maize-
soya based diet throughout the three trails. 
  
In the first trial, garlic and a commercial prebiotic (Bio-Mos®), were tested and compared in terms of 
AND and AAD, to an antibiotic (doxycyclin, Doxyvete-SOS). A starter and finisher diet were fed as 
either mash or pellets. The garlic was included at 8g/kg, 13g/kg and 18g/kg to the starter and finisher 
diets. Bio-Mos® was added at 1g/kg, 2g/kg and 3g/kg to the starter diet, and 0.5g/kg, 1g/kg and 
1.5g/kg to the finisher diet. The doxycyclin was added at 0.3 g/kg. None of the treatments had any 
beneficial effects in terms of AND. Feeding a pellet seem to have some negative effects in terms of 
AND. In general most of the treatments did not show any improvement in AAD at any determination 
period (day 21, 28 or 35). At day 21 and day 35, the mash diet supplemented with 18g/kg garlic had a 
negative effect on AAD, when compared to the negative and positive control. It doesn’t seem that 
feeding either a mash or a pellet had an influence on the effects exerted by the different treatments.  
 
In the second trial the influence of Bio-Mos®, a blend of organic acids, probiotics and electrolytes 
(Acid-Pak 4-way®) and a medium-chain triglyceride (MCT) were evaluated and compared in terms of 
AAD and AND, to the effect of an antibiotic, doxycyclin. The starter and finisher diets were fed as a 
mash. Bio-Mos® was included at 1g/kg, 2g/kg, and 3g/kg in the starter diet, and at 0.5g/kg, 1g/kg, 
1.5g/kg in the finisher diet, respectively. Acid-Pak 4-way® was included at 0.4g/kg, 1g/kg and 1.6g/kg 
for both the starter and finisher diets. Medium-chain triglycerides (MCT) were allocated at 3g/kg, 
3.6g/kg, 4.2g/kg for the starter diet, and 2.1g/kg, 2.7g/kg and 3.4g/kg for the finisher diet. An antibiotic, 
doxycyclin, was included at 0.3 g/kg. With AND, no treatment had any significant effect for the entire 
experimental period. At day 21, the treatment supplemented with MCT (3.4g/kg) had the most 
significant beneficial effect on AAD, when compared to the negative- and positive controls, as it 
increased AAD for the majority of the amino acids. The treatment with Acid-Pak 4-way® (1g/kg) had 
the most significant negative effect on AAD when compared to the positive control. At day 28, the 
treatments with Bio-Mos® (0.5g/kg and 1.5g/kg) and Acid-Pak 4-way® (0.4g/kg) had the most 
significant beneficial effect on AAD when compared to the positive control. It increased AAD for more 
than half of the 17 amino acids evaluated. The treatment supplemented with MCT (2.7g/kg) has 
shown the most significant negative effect on AAD, when compared to the positive control.  
 
In the third trial the effect of Bio-Mos®, Acid-Pak 4-way® and MCT on production performance was 
evaluated, and compared to the effects of the presence or absence of doxycyclin. Body weight (BW), 
body weight gain (BWG), feed intake (FI) and feed conversion ratio (FCR) were measured.  The 
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 starter and finisher diets were fed as a mash. Bio-Mos®, MCT and Acid-Pak 4-way® were included at 
3.0g/kg, 4.2g/kg and 1.6g/kg, respectively in the starter and finisher diets. Birds were weighed (per 
pen) on arrival and on days 7, 14, 21, 28, 35. Feed intake (FI) per pen was measured at days 7, 14, 
21, 28 and 35, and mortality was recorded daily. In terms of BWG, Acid-Pak 4-way® had a higher 
BWG, when compared to the negative control, Bio-Mos® and MCT.  
 
It can be concluded that Bio-Mos®, Acid-Pak 4-way®, as well as MCT can be a possible alternatives 
to antibiotic supplementation. These three treatments did not necessary prove to be more effective 
than antibiotics, but are definitely competitive alternatives.  
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 OPSOMMING 
 
Verskillende behandelings is geëvalueer en vergelyk met ‘n antimikrobiese produk, in terme van hul 
uitwerking op stikstof - en aminosuur verteerbaarhede. Twee verteringstudies en produksieprestasie 
studie is uitgevoer.  
 
In die eerste twee studies is die skynbare stikstof (AND)- en aminosuur (AAD) verteringskoöeffisiënte 
bepaal deur gebruik te maak van digesta wat by die terminale ileum ingesamel is (ileale 
verteringsmetode). In die derde studie is die produksie prestasie van braaikuikens op ‘n 
gebalanseerde metaboliseerbare energie (AME) rantsoen, soos beïnvloed deur die verskillende 
behandelings, geëvalueer.  
 
In die eerste studie is knoffel en ‘n kommersiële prebiotikum (Bio-Mos®) geëvalueer en met ‘n 
antibiotikum (doksisiklien, Doxyveto-SOS) in terme van AND en AAD vergelyk. Beginner- en 
afrondingsrantsoene is as ‘n meel of pille gevoer. Die knoffel is teen 8g/kg, 13g/kg en 18g/kg in die 
rantsoen ingesluit. Bio-Mos® is teen 1g/kg, 2g/kg en 3g/kg in die beginner rantsoen en teen 0.5g/kg, 
1g/kg en 1.5g/kg in die afrondingsrantsoen, ingesluit. Die antibiotikum is teen 0.3g/kg in beide 
rantsoene ingesluit. Geen van die behandelings het enige positiewe invloed op AND gehad nie. Deur 
‘n verpilde rantsoen te voer het sekere negatiewe invloed op AND gehad. Oor die algemeen het geen 
behandelings enige positiewe invloed op AAD gehad nie. Op dag 21 en 35 het die insluiting van 
knoffel teen 18g/kg in ’n meel rantsoen ’n negatiewe invloed op AAD gehad, wanneer dit met die 
negatiewe- en positiewe kontroles vergelyk is. Dit blyk nie dat om ‘n pil of meel te voer enige invloed 
op die invloede van die verskillende behandelings gehad het nie.   
 
In die tweede studie is Bio-Mos®, ‘n organiese suur (Acid-Pak 4-way®) en ‘n medium-ketting 
trigliseried (MCT) geëvalueer en met ‘n antbiotikum, doksisiklien (Doxyveto-SOS) in terme van AND 
en AAD, vergelyk. Beginner- en afrondingsrantsoene is gevoer as ‘n meel. Bio-Mos® is teen 1g/kg, 
2g/kg, and 3g/kg in die beginner rantsoen en teen 0.5g/kg, 1g/kg, 1.5g/kg in die afrondingsrantsoen, 
ingesluit. Acid-Pak 4-way® is teen 0.4g/kg, 1g/kg en 1.6g/kg vir die beginner –en afrondingsrantsoene 
ingesluit. Die MCT is teen 3g/kg, 3.6g/kg, 4.2g/kg in die beginner rantsoen en teen 2.1g/kg, 2.7g/kg en 
3.4g/kg in die afrondingsrantsoen ingesluit. Die antibiotikum is ingesluit teen 0.3g/kg. Geen 
behandelings het enige betekenisvolle invloed in terme van AND gehad nie. Op dag 21 het MCT 
(3.4g/kg), in vergelyking met die negatiewe- en positiewe kontrole, die grootste positiewe invloed op 
AAD gehad. Acid-Pak 4-way® (1g/kg) het, in vergelyking met die positiewe kontrole, ‘n positiewe 
invloed gehad op AAD. Op dag 28, het Bio-Mos® (0.5g/kg en 1.5g/kg) en Acid-Pak 4-way® (0.4g/kg) 
die grootste positiewe invloed op AAD gehad. Die behandeling met MCT (2.7g/kg) het die mees 
negatiewe invloed op AAD gehad. 
 
In die derde studie is die insluiting van Bio-Mos®, Acid-Pak 4-way® en MCT getoets om die invloed op 
braaikuiken produksie prestasie te evalueer, en te vergelyk met die invloed van die insluiting of 
afwesigheid van ‘n antibiotikum. Liggaamsmassa (BW), liggaamsmassa toename (BWG), voerinname 
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 (FI) en voeromsetverhouding (FCR) is gemeet. Beginner- en afrondings rantsoene is gevoer as ‘n 
meel. Bio-Mos®, MCT en Acid-Pak 4-way® is onderskeidelik teen 3.0g/kg, 4,2g/kg en 1.6g/kg in die 
rantsoen ingesluit. Die kuikens is met aankoms (per hok) geweeg, asook op dae 7, 14, 21, 28, 35. 
Voerinname per hok is gemeet op dae 7, 14, 21, 28 en 35. Mortaliteite is daagliks aangeteken. Die 
insluiting van Acid-Pak 4-way® het in vergelyking met die negatiewe kontrole, Bio-Mos® en MCT 
insluiting ‘n hoër BWG tot gevolg gehad.  
 
Die gevolgtrekking wat gemaak kan word is dat Bio-Mos®, Acid-Pak 4-way® en MCT gebruik kan 
word as ‘n moontlike alternatief vir antibiotika insluiting. Hierdie drie behandelings was nie 
noodwending meer effektief as die antibiotika nie, maar het wel bewys dat dit kompeterende 
alternatiewe is.  
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Chapter 1 
General introduction 
 
The main aim of nutrition is to optimise production efficiency under intensive farming conditions. This 
is usually achieved when flock health is optimised as well (Whitehead, 2002). As a result, broiler diets 
are supplemented with a number of additives aimed at improving performance, feed intake and 
thereby optimizing feed utilization (Whitehead, 2002; Wenk, 2003). The growing pressure from 
consumers on welfare organizations and non-governmental organizations to produce safe and healthy 
food has become an area of great concern. Human and animal health, as well as the protection of the 
environment should be considered in modern farming systems. 
 
Enteric diseases are a great concern in the poultry industry due to the loss of productivity and increase 
in mortality. Therefore, the role of antibiotics in preventing these enteric diseases has long been 
investigated. An antibiotic can be defined as a chemically complex antimicrobial substance derived 
from microbial fermentation or synthetic structural derivatives thereof, and that is antagonistic to 
microbial growth in very low concentration (ACVM Group, 2000). Antimicrobial growth promoters 
(AGPs) are antibiotics that are included at low levels in rations. At inclusion levels that are lower than 
therapeutic levels, antibiotics can enhance animal growth and feed efficiency (Maritz, 2005). 
 
Antimicrobials are mainly used in animal production for the treatment and healing of disease. 
However, it can also be used as growth promoters. The use of antibiotics as growth promoters has 
made intensive farming possible by means of improved production efficiency through the improvement 
of feed conversion of animals (Hernandez et al., 2004). The argument about the use of antibiotic 
growth promoters (AGPs) is part of a worldwide debate about practices of intensive animal farming 
(Maritz, 2005). There are some concerns regarding the use of antimicrobials as growth enhancers and 
as a result, alternative feed formulation and management strategies that exclude antimicrobial growth 
promoters must be developed and evaluated under intensive farming conditions (Collet & Dawson, 
2001). Therefore there has been a search for alternative substances to replace antibiotics. Possible 
alternatives include probiotics, prebiotics, feed enzymes and organic acids. 
 
The main objective of this thesis was to evaluate a number of alternative substances to replace 
antibiotics as a feed additive in poultry rations and to determine the potential positive or negative 
effects it may have on production performance and protein digestibility in broilers. 
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Chapter 2 
Literature Review 
 
2.1 Introduction 
 
A large percentage of the feed ingredients consumed by a chicken are in a form that requires chemical 
and other reactions before it can be utilized by the bird. The alimentary canal is a long tube through 
which the food passes while these reactions take place. Therefore, digestion can be described as 
those changes that occur in the alimentary canal to make it possible for feed to be absorbed through 
the intestinal wall and enter the bloodstream (North & Bell, 1990). 
 
The small intestine is the part of the intestinal tract where most of the digestion and absorption of 
nutrients take place (Dibner & Richards, 2004). It consists of three parts, i.e. the duodenum, jejunum 
and ileum. The pancreas is imbedded in the duodenal loop, and secretes the enzymes that are 
essential in the digestion of lipids (i.e. lipases), starch (i.e. amylases) and proteins (i.e. proteases) in 
the small intestine. Another function is to neutralize acids that are found in the mixture passed on from 
the stomach. Most of the absorption takes place in the jejenum. The third section, the ileum, is where 
enzymes are produced, and contains mainly indigestible material. Bile secreted by the liver, assists 
with digestion by breaking up large particles, especially fat. The lower part of the intestinal tract 
consists of the colon and the ceca. These two parts contain mostly the indigestible portions of the 
feed, i.e. fibre (cellulose). No digestion or absorption of nutrients takes place here (Dibner & Richards, 
2004; Guo et al., 2004a, North & Bell, 1990). 
 
Intestinal microflora of animals play an important role in the health status, and especially in the 
digestion and absorption of feed ingested by the host. It takes part in the metabolism of dietary 
nutrients such as carbohydrates, protein, lipids and minerals and also in the synthesis of vitamins (Jin 
et al., 1997). Whilst pathogenic bacteria are always present in the gut, the balance of non-pathogenic 
and pathogenic bacteria will strongly influence the disease status of the bird. Intestinal bacteria can be 
divided into species that exert either harmful (pathogenic) or beneficial effects. The intestinal tract 
contains many micro-organisms like bacteria or viruses. Some of these organisms are harmless and 
aid in digestion. However, others cause tremendous problems e.g. Salmonella enteritidis and are 
difficult to eliminate (Guo et al., 2004b). Other organisms do not actually cause disease, but impair the 
functioning of the digestive enzymes. Therefore, a common approach to maintain health of the host 
animal is to increase the number of desirable bacteria in order to inhibit colonization of invading 
pathogens. The composition and activity of intestinal microbiota can be altered by diet composition 
and dietary manipulations such as the use of feed additives and antibiotics (Guo et al., 2004b).  
 
Chickens are stressed by various factors such as transportation to the growing site, overcrowding, 
vaccination, chilling and/or overheating. These factors tend to create an imbalance in the intestinal 
microflora and a lowering of body defence mechanisms. Under such circumstances, antimicrobial feed 
additives are often used to suppress or eliminate harmful organisms in the intestine, and to improve 
University of Stellenbosch: http://scholar.sun.ac.za
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growth and feed efficiency (Jin et al., 1997). Enteric diseases are a problem that continuously 
challenges the poultry industry through the loss of productivity, increased mortality, and associated 
contamination of poultry products (Patterson & Burkholder, 2003). It is therefore that so-called 
bacterial suppressants are added to the feed to depress the proliferation of those bacteria which are 
harmful to digestion, and thus lowers feed conversion. Moore et al. (1946) reported on the first 
research that indicated the positive effects of antibiotics, such as sulfasuxidine, streptothricin, and 
streptomycin on chicken growth. 
 
2.2 Antibiotics 
 
Antibiotics have commonly been used in the poultry feed industry in various ways, to improve growth 
and feed utilisation efficiency and also as a tool in the efficient production of animal products such as 
milk, meat, eggs and feathers. Therapeutic use involves administering antimicrobials at the highest 
regulated inclusion levels for a limited period to individual animals showing signs of disease. 
Prophylactic use involves antimicrobial inclusion for a limited period to large or small groups of healthy 
animals deemed to be at risk of disease caused by pathogens susceptible to drugs (Cromwell, 1999; 
ACVM Goup, 2000).  
 
The benefits of AGP’s in animal production can be identified as environmental, performance 
enhancing and the control of disease. AGP’s modify the intestinal flora to improve digestion, 
metabolism and absorption of a variety of essential nutrients. They eliminate Gram-positive bacteria 
that are associated with the production of undesirable or toxic metabolites and therefore, poorer health 
and performance of the animal. There are additional direct effects on gut morphology such as 
increased villus height and surface area and increased mucin secretion. The result is an optimal 
environment for the intestinal mucosa, which allows efficient nutrient absorption. Consequently 
nutrient utilization, feed conversion ratio and weight gain are improved. The effect of antibiotics is 
prominent in young growing animals especially under poor climatic and management conditions 
(ACVM Group, 2000; Van Immerseel et al., 2002; Wenk, 2003).  
 
The effect of withdrawal of dietary antibiotics on growth and feed conversion efficiency of different 
farm animals is represented in Table 2.1.  
 
Table 2.1 Effect of withdrawal of antibiotics as performance promoters on growth performance and 
feed conversion efficiency in different species of farm animals (Wenk, 2003). 
 Reduction in daily body mass gain (%) Increase in feed per gain (%)
Veal calf production  7-8 4-5 
Beef production 4 2 
Weaned piglets 8 5 
Growing pigs 5 3 
Fattening pigs 2 1 
Pig production 5 2 
Growing chickens 3 2 
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According to Wenk (2003), the withdrawal of antibiotics had the greatest effect on reduction in daily 
body mass gain in veal calf production and weaned piglets, but seems to have less effect on fattening 
pigs and growing chickens. It also had the greatest effect on feed intake in veal calf production and 
weaned piglets.     
 
The controversy surrounding the use of in-feed antimicrobials arises from their use as growth 
promoters, where antimicrobials are administered to large numbers of healthy animals for long periods 
at low concentrations, in order to increase the rate and efficiency of growth. The continued use of 
these AGP’s at sub-therapeutic levels has caused concern amongst consumers to the extent that they 
have forced legislators in Europe to take action regarding the use of AGP’s in animal feeds (ACVM 
Group, 2000; Sun et al., 2005). Antibiotic feed additives were linked to the emergence of multiple drug 
resistant bacteria. The increase in the level of resistance in bacteria against many of the commonly 
used antibiotics in human medicine therefore raised major concerns, which resulted in the search for 
alternatives (Collett & Dawson, 2001; Van Immerseel et al., 2002). Improved bio security, vaccination 
and genetic selection are some strategies that can be followed to reduce the use of antibiotics (Sun et 
al., 2005). 
 
A successful alternative to AGP’s should comply with certain characteristics. It should be able to mimic 
the mode of action or effect of the antimicrobial, and therefore have a significant beneficial impact on 
animal production and health which can be reflected in improved digestion, nutrient metabolism and 
absorption, as well as a decrease in incidence of diseases. It should also be generally regarded as 
safe (GRAS) to both the animal and human, be easy to apply and store and be cost-effective. Dry 
powder products, for instance, are easier to handle than liquid products. Low inclusion rates, heat 
stability and long shelf-life are all qualities that will make the product more attractive (Collett & 
Dawson, 2001). 
 
2.3 Probiotics and Prebiotics 
 
Probiotic and prebiotic foods have been consumed by humans for centuries, either as natural 
components of food, or as fermented foods. The poultry industry has become conscious of the use of 
probiotics and prebiotics as a potential alternative for antibiotics. Table 2.2 shows the characteristics 
of probiotics and prebiotics. The proposed mechanisms by which probiotics and prebiotics exert their 
effects, include competition for substrates, production of toxic compounds that inhibit pathogens, and 
competition for attachment sites (Patterson & Burkholder, 2003; Angel et al., 2005). Table 2.3 shows 
the general beneficial effects of probiotics and prebiotics. 
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Table 2.2  Characteristics of ideal probiotics and prebiotics (Patterson & Burkholder, 2003). 
Probiotics Prebiotics
Be of host origin Be neither hydrolised or absorbed by mammalian 
enzymes or tissues. 
Non-pathogenic Selectively enrich for one or a limited number of 
beneficial bacteria. 
Withstand processing and storage Beneficially alter the intestinal microbiota and their 
activities. 
Resist gastric acid and bile Beneficially alter luminal or systemic aspects of the 
host defence system. 
Adhere to epithelium or mucus  
Persist in the intestinal tract  
Produce inhibitory compounds  
Modulate immune response  
Alter microbial activities  
 
Table 2.3 Beneficial effects of probiotics and prebiotics  (Patterson & Burkholder, 2003). 
Probiotics Prebotics
Modify intestinal microbiota Increase production of volatile fatty acids (VFA) 
Stimulate immune system Increase biomass and stool bulking 
Reduce inflammatory reactions Increase B vitamin synthesis 
Prevent pathogen colonization Improve mineral absorption 
Enhance animal performance Prevent cancer 
Decrease carcass contamination Lower serum cholesterol 
Decrease ammonia and urea excretion Lower skatole-, indole-, phenol production, etc. 
 
2.3.1 Probiotics 
 
An alternative method for modifying the gut microflora involves the feeding of probiotics (Whitehead, 
2002). Probiotics, or otherwise known as direct-fed microbials (DFM’s), can be defined as live 
microbial feed supplements that beneficially affect the host animal by improving its intestinal microbial 
balance (Fuller, 1989; Collett & Dawson, 2001; Angel et al., 2005). The statement about probiotics 
being “live” cells differentiates them from chemical modifiers of the intestinal environment (Partridge, 
1991).  
 
The intestine has a mucosa which works as a selective barrier allowing the passage of useful 
substances and preventing the entering of undesirable agents into the bloodstream. Therefore the 
health of this mucosa is essential for efficient feed conversion, maintenance and growth, and thus to 
the well-being of the animal,. Healthy birds are generally considered as having a well functioning 
intestinal tract, and an important characteristic of a healthy, well-functioning intestinal tract is the 
balance of its microbial population. When animals are stressed through factors such as overcrowding, 
environmental fluctuations, handling and transport, the population balance of the intestinal microflora 
gets disturbed. This tends to favour the development of pathogens. The aim of probiotics is to 
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maintain the population balance in favour of beneficial bacteria. It has been found that continuous 
probiotic supplementation aid in maintaining that balance (Jin et al., 1997; Cencic et al., 2006).  
 
2.3.1.1 Modes of action 
 
Probiotics that have been specifically investigated for use in livestock include Bacillus, Enterococcus, 
Lactobacillus, Saccharomyces and yeast cultures (Patterson & Burkholder, 2003). The benefits of 
probotics are based on two main functions, i.e. stimulating the growth of beneficial microflora in the 
gastrointestinal tract and suppression of the growth of pathogenic bacteria by means of competitive 
exclusion (Wenk, 2003). It has been proposed that probiotics compete for substrates, produce toxic 
compounds inhibitory to pathogens, and competitively exclude potentially pathogenic bacteria by 
adhering to attachment sites. Mixed bacterial cultures reduce intestinal wall colonisation of pathogens 
and, therefore, reduce the quantity of toxins produced (Patterson & Burkholder, 2003).  
 
Studies have shown that a low pH in the upper small intestine of monogastric animals helps to 
suppress the growth of pathogens such as Escherichia coli or Salmonella. Therefore probiotics used 
in poultry should stimulate the formation of lactic acid bacteria (LAB) (Wenk, 2003). The antagonistic 
activity of LAB towards pathogens can be attributed to the production of bacterial substances. Among 
those produced by lactobacilli are bacteriocins, organic acids and hydrogen peroxide. Bacteriocins are 
defined as compounds produced by bacteria that have a biologically active protein moiety and a 
bactericidal action. Antagonism by lactic acid bacteria has also been associated with major end 
products of their metabolism. The best known are organic acids such as lactic and acetic acids and 
hydrogen peroxide. Acetic and lactic acids inhibit the growth of many bacteria including pathogenic 
Gram-negative organisms (Jin et al., 1997).       
 
Another approach is a technique called competitive exclusion. It was found that the resistance, of 
newly hatched chickens, against Salmonella infection could be increased by dosing them with a 
suspension of gut contents derived from healthy adult chickens (Jin et al., 1997; Van Immerseel et al., 
2002). 
 
The gastrointestinal tract of the chick is immunologically prone to rapid colonization by beneficial and 
pathogenic bacteria during the first 3 to 4 weeks post-hatch (Sun et al., 2005). To avoid transmission 
of any unsuspected pathogenic bacteria present in the intestinal suspension to the host animals, the 
components of the protective intestinal flora have to be known.  
 
2.3.1.2 Studies 
 
Researchers have reported that supplementing broiler and layer diets with probiotics leads to 
improved production performance. Numerous studies with broilers have indicated that 
supplementation with probiotic preparations improve live weight gain and feed conversion rate, and 
markedly reduce mortality. It has also been reported that the supplementation of probiotics increases 
the egg production and feed conversion of layers (Jin et al., 1997). Literature suggests that the effects 
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may vary between preparations as well as with different environmental and management conditions 
(Priyankarage et al., 2003b).  
 
Variation in the effects of probiotics on chickens, can possibly be ascribed to differences between the 
strains and forms of bacteria used, as well as to differences in the level of inclusion in animal diets. 
The lack of consistency in results contributes to the uncertainty of the positive effects of probiotics in 
chickens. Given the correct strain of bacteria, optimal concentration in the diets and relatively stress-
free conditions, probiotic supplementation should have beneficial effects on production performance in 
broilers (Jin et al., 1997; Olnood et al., 2007).  
 
Broilers 
 
Several studies found that broilers gained more weight when fed diets supplemented with commercial 
lactobacilli, compared to birds fed diets without the supplementation of commercial lactobacilli. The 
birds that were fed lactobacilli in the feed had significantly lower feed to gain ratio i.e. amount of feed 
needed to gain weight. When adherent Lactobacillus cultures, isolated from the GIT of chickens, were 
used there was an improvement in body weight and feed to gain ratios. It was found that the highest 
growth rate was obtained when broilers were fed a concentration of 0.1% Lactobacillus cultures (Jin 
et.al, 1997).  
 
Yeo and Kim (1997) reported that feeding a diet containing a probiotic (Lactobacillus casei) 
significantly increased the average daily weight gain during the first three weeks of the study period. 
This increase in weight gain was partly accounted for by increased feed intake. It also indicated a 
significant decrease (P<0.05) in urease activity in the small intestine of young chicks and can therefore 
be beneficial for improving animal health and growth.  
 
Another study tested three different commercial probiotic mixtures and compared it to a commercial 
antibiotic growth promoter. It was found that the weight improvement of the birds fed on the probiotic-
containing diets was comparable with birds fed on the antibiotic-containing diets. Significant (P<0.05) 
positive effects were accomplished only during the starter period for both probiotics and antibiotics 
(Priyankarage et al., 2003b).  
 
In a study where a live probiotic product containing Enterococcus faecium were compared against a 
negative control (i.e. containing no antibiotic treatment), some positive effects were found. Weight gain 
and feed conversion ratio were significantly (P<0.05) improved. The same probiotic was also tested 
against a diet containing antibiotic treatment, but no significant differences were found in terms of 
performance. These results demonstrate that probiotics can act as a viable alternative to antibiotic 
feed additives (Leary & Partridge, 2008).  
 
There are also studies that produced no positive results in terms of production performance. A study 
with host-specific and non-host specific Lactobacillus, as well as a commercial product containing 40 x 
109 cfu/ml Lactobacillus showed no improvement in chicken growth. Another study found no significant 
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(P≥0.05) difference in body weight of chickens fed with diets containing L. acidophilus and S. faecium 
from 8-60 days of age (Jin et al., 1997). Another study with a commercial probiotic (Protexin) showed 
no significant effect on the performance of the birds (Priyankarage et al., 2003a).  In another trial 
conducted with Cobb broiler chickens, four Lactobacillus strains were compared to an antibiotic. The 
addition of probiotic Lactobacillus spp. to the feed did not improve body weight gain (BWG), feed 
intake (FI) and feed conversion ratio (FCR) (Olnood et al., 2007).   
 
Layers 
 
Probiotics have also been tested in laying birds. In layers probiotic supplementation also indicated an 
increase in egg production and feed conversion (Jin et al., 1997). A series of studies were done to 
investigate the effects of Lactobacillus on layer performance, where either 1100mg/kg or 2200mg/kg 
Lactobacillus were fed. An increase in egg size, egg mass, and egg weight, as well as an 
improvement in body weight gain was observed. Egg production, however, was not influenced by 
either of the two treatments. Diets supplemented with Lactobacillus also increased feed consumption 
and body weight gain in pullets from 7-19 weeks. During the laying phase (20-59 weeks), layers fed a 
diet with Lactobacillus produced larger eggs than those fed a similar diet without Lactobacillus 
(Nahashon et al., 1996). Tortuero and Fernandez (1995) reported that supplementation with a mixed 
culture of L. acidophilus and L. casei improved hen-day egg production, feed conversion ratio, egg 
weight and albumen quality. Mohan et al. (1995) found a 5% improvement in egg production in layers 
fed a diet supplemented with 100 mg/kg probiotic.  
 
Goodling et al. (1987) reported no increase in hen-day egg production, feed efficiency, and egg size in 
the case of layers fed a liquid non-viable Lactobacillus product, a dried non-viable Lactobacillus 
product, or a viable Lactobacillus product during a 48 week experimental period. The reasons for the 
ineffectiveness of Lactobacillus were because of the non-host specific Lactobacillus used and the fact 
that the birds were being kept under relatively ideal conditions. 
 
2.3.2 Prebiotics 
 
Prebiotics are defined as non-digestible food ingredients that beneficially affect the host by selectively 
stimulating the growth and/or activity of one or a limited number of bacterial species already resident 
in the colon, and thus attempt to improve host health. They occur naturally in some feedstuffs of plant 
origin and in lower organisms like yeast cells (Fenster, 2001). 
 
In principle only non-digestible, fermentable feed components are prebiotics. Most of these prebiotics 
are carbohydrates. These carbohydrates are divided in groups such as mono-, di-, oligo- and 
polysaccharides, based on their molecular length (Van Immerseel et al., 2002; Wenk, 2003). 
Carbohydrates have been used as prebiotics to influence the composition of the bacterial populations 
in the large intestine (Guo et al., 2004b).  
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2.3.2.1 Modes of action 
 
Prebiotics are always feed ingredients that are not digested by the host, none or little used and/or 
metabolised as they pass through the upper portion of the intestinal tract, so that they can reach the 
flora of the large intestine. Secondly, prebiotics have to be able to serve as a substrate for one or 
more bacterial species and should also have a potentially beneficial effect on the host, and finally, they 
have to be able to cause a shift in the microflora in the gut that improves the health of the host (Gibson 
& Roberfroid, 1995; Van Immerseel et al., 2002; Patterson & Burkholder, 2003).  
 
The prebiotics most predominantly studied are fructo-oligosaccharide products (FOS, oligofructose, 
inulin) but research into the use of other possible compounds has been conducted (Gibson & 
Roberfroid, 1995). Fructo-oligosaccharide products (FOS) have demonstrated some potential for 
improving the health and growth rates of poultry (Collet & Dawson, 2001). Prebiotics can bind with 
fimbria of pathogenic Gram-negative bacteria, such as E.coli and Salmonella. Mannan-
oligosaccharides (MOS), derived from yeast cell walls, also bind the fimbria of pathogenic bacteria 
(e.g. E.coli, Salmonella) to prevent them from attaching to, and therefore colonizing on, the mucosa of 
the small intestine. Diets supplemented with MOS affect a chicken’s intestinal microflora (i.e. 
increasing villus height; improving uniformity and integrity) and reduce susceptibility to S. enteritidis 
colonization (Fenster, 2001; Patterson & Burkholder, 2003; Sun et al., 2005).   
 
2.4 Synbiotics 
 
Prebiotics and probiotics are only two of quite a few approaches that have the potential to reduce 
enteric diseases in poultry. The combination of these two additives is known as synbiotics (Patterson 
& Burkholder, 2003). Synbiotics can also be defined as products produced by fermentation. The 
combination could improve the survival of the probiotic organism, because its specific substrate is 
available for fermentation. The advantages offered by both the live microorganism and the prebiotic 
can be beneficial to the host. Examples of synbiotics are FOS, Bifidobacteria, lactitol and Lactobacilli 
(Van Immerseel et al., 2002). 
 
2.5 Essential oils, herbs and botanicals  
 
Herbs, spices and various plant extracts have received increased attention as possible antibiotic 
growth promoter replacements. The mere fact that plant or herbal extracts are natural makes it a 
preferred choice as an alternative to antibiotics for consumers (Hernandez et al., 2004).  
 
Herbs are non-woody, flowering plants famous for its’ medicinal properties, flavour and aroma. Spices 
are defined as any of a class of spicy or aromatic substances of vegetable origin such as pepper, 
cinnamon and cloves used e.g. for seasoning and as preservatives. A drug made from a part of a 
plant, is known as a botanical. Plant extracts or essential oils possessing a distinct aroma are used 
mainly in the production of perfumes, flavourings and pharmaceuticals, but some are also of interest in 
animal nutrition because of their antimicrobial and antioxidative properties (Wenk, 2003).  
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Essential olis, herbs and botanicals used in animal feed are reported to have a beneficial effect by 
promoting feed intake and digestive secretions, stimulating the immune system. They may also have 
antibacterial, coccidiostatic, antiviral, anti-flammatory and antioxidant properties (Wenk, 2003). Plant 
extracts could control and limit the growth of numerous pathogenic and non-pathogenic species of 
bacteria in the gut (Hernandez et al., 2004). Plants are rich in a wide array of secondary metabolites, 
such as tannins, terpenoids, alkaloids, and flavonoids, which have been found to have antimicrobial 
properties in vitro (Cowan, 1999; Lewis et al., 2004). The fragrance of plants is carried in the so-called 
essential oil fraction. These oils are secondary metabolites that are highly enriched in compounds 
based on an isoprene structure, and they are called terpenes. When the compounds contain additional 
elements, usually oxygen, they are termed terpenoids. Terpenoids are synthesized from acetate units, 
and as such they share their origins with fatty acids. They differ from fatty acids in that they contain 
extensive branching and are cyclized. Terpenoids activate against multiple types of microorganisms 
such as Gram-positive - and Gram-negative bacteria, fungi and protozoa (Cowan, 1999). 
 
These type of additives can be difficult to regulate, because they may contain unacceptable levels of 
pesticides, heavy metals and other contaminants. It is also difficult to measure the activity of the 
relevant compounds in these additives and variation in activity may be due to differences in 
geographical growing areas, season, harvesting time, storage conditions and extraction method.  
 
2.5.2 Studies 
 
A few studies have been conducted to test the possible antimicrobial properties in several plant 
extracts. 
 
Lewis et al (2004) tested broiler performance between 7 and 27 days of age. In this study garlic 
(Allium vineale), horseradish (Armoracia rusticana), juniper (Juniperus species), milk thistle (Silybum 
marianum), oregano (Oreganum vulgare) and yarrow (Achillea millefolium) were tested. The birds 
were fed a basal diet (control) which was supplemented with either an acid blend or one of the 
botanical extracts. All of the plant extracts were allocated at 2 (higher and lower) concentrations. Feed 
consumption and weight gain were measured. No treatment differences were observed in any of the 
performance parameters measured during day 7 to day 17 of age. The differences only became 
significant from day 17 to day 27 of age. The birds that were fed on the higher levels of garlic and 
yarrow showed the best feed conversion efficiency (FCE) (P<0.05). Birds fed on the higher level of 
garlic also tended (P=0.079) to have higher weight gains. Another study investigated the effect of five 
herbal natural feed additives i.e. Nor-Spice, Oregano Powder, Du-Sacch C Powder (FOS), Quiponin S 
Powder (products from the Quillaia saponaria tree), Nor-Spice S Garlic Powder and Nor-Spice Thyme 
Powder as alternatives for antimicrobial growth promoters. Growth performance and some intestinal 
traits in broilers were tested. Garlic resulted in higher body weight gains at 14 days (P<0.05). Birds fed 
garlic, quiponin, thyme and antibiotic in their diets consumed more feed than the broilers fed Du-Sacch 
(P<0.05). Between days 0 to 42 the supplements had no effect on body weight gain, feed intake and 
feed:gain ratio (P>0.05). However, from days 0-14 the chickens fed on quiponin, garlic and thyme 
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gained more body weight than the chickens fed on the diets supplemented with an antibiotic (Demir et 
al., 2005).  
 
In a study a Chinese herbal medicine (CHM) formulation was tested and compared to an antibiotic 
(virginiamycin). The CHM consisted of 14 herbs and was allocated at four different concentrations. 
The herbs were processed and ground prior to addition to the feed. The CHM dietary treatments 
produced increased body weight gain at days 7-21, compared to the VRG groups. However, no 
increase in body weight gain was detected at days 21-28. The CHM groups also had a higher feed 
intake (FI) and feed conversion ratio (FCR) than the VRG groups between days 21-28. It was 
concluded that the only considerable increase in growth performance with the CHM groups happened 
between days 7-21 but not afterwards (Guo et al., 2004a). Another study was conducted to compare 
the effect of an organic acid (formic acid) and plant extracts (blend of oregano, cinnamon, and pepper 
essential oils) to that of and an antibiotic (avilamycin). It was found that the effect of formic acid and 
the plant extract were similar to avilamycin, and that these compounds were beneficial for improving 
growth traits and nutrient apparent ileal digestibility. A positive effect of formic acid on intestine 
mucosa was also observed (García et al., 2007). Broiler chicks were also fed four levels of dried garlic 
for 35 days. It has proved to increase average daily weight gain (P<0.05) during the first 21 days 
(Horton et al., 1992). 
 
Another study proved that garlic can also be beneficial in other species, such as pigs. A study was 
conducted with growing-finishing pigs. A herb mixture containing great nettle (Urtica dioica), garlic 
(Allium sativum) and wheat-grass (Agropyron repens) were included in the feed. These herb mixture 
supplementations have improved (P<0.05) daily gains in the growing and finishing periods by 6% and 
5% respectively. The herb mixture treatment resulted in a 10% lower (P<0.05) feed conversion ratio 
(FCR) than the control diet. (Grela et al., 1998).  
 
2.6 Organic acids 
 
Supplementing diets with organic acids can also cause enhanced growth, improved performance and 
increased productivity. Organic acids can suppress pathogenic bacteria in the intestine by lowering the 
pH, and therefore providing an unfavourable acidic environment for their functioning and proliferation. 
The faster the acids are absorbed, the smaller the pH lowering effect. This effect is directly influenced 
by the acid binding capacity of the diet. Furthermore, the digestibility of nutrients can be improved by 
organic acids (Wenk, 2003). By adding organic acids to the drinking water, it was shown to decrease 
Campylobacter numbers in the caeca (Sun et al., 2005). 
 
A mixture of dietary organic acids lowered the mortality rates during the first two weeks of the birds’ 
life. It was also indicated that, in general, dietary organic acids improve growth performance and 
nutrient digestibility when fed to pigs (Pirgozliv et al., 2007). The practice of acidifying poultry starter 
diets and drinking water systems was initially introduced as a means of improving animal health 
through the prevention of pathogen-induced intestinal upset. A study done with broilers, with 
acidification of drinking water with a mixture of organic and inorganic acids decreased mortality and 
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inproved feed conversion. Results are shown in Table 2.4. The salt content and the buffering capacity 
of the diet can influence the effect of the acids (Collet & Dawson, 2001). 
 
Table 2.4. Effects of acidification on mortality and feed efficiency of broilers (Collet & Dawson, 2001). 
  Control Acidification of water 
Flock #1   
Number of birds 20 000 20 000 
Mortality 3.1 2.9 
Feed conversion  1.96 1.91 
Flock #2   
Number of birds 20 000 20 000 
Mortality 3.5 3.0 
Feed conversion 1.95 1.91 
 
Organic acids can be metabolised, and therefore also represent an energy source. Finally they can 
also improve the hygienic quality of meat with the suppression of undesired microorganisms like 
Salmonella or Campylobacter (Wenk, 2003).  
 
2.7 Medium-Chain Triglycerides (MCT) 
 
Medium-chain triglycerides (MCT) have fatty acids 6 to 12 carbon atoms long and can be easy utilized 
by pigs and chickens as an energy source. Medium-chain triglycerides can be more easily digested 
and absorbed than long-chain fatty acids, mainly because of their size and solubility (Lee & Chiang, 
1994; Turner et al., 1999). A study with neonatal pigs indicated that MCT was effective as an energy 
source, but did not improve growth or survival from birth to weaning (Lee & Chiang, 1994).   
 
2.8 Aim of study 
 
There are limited reports available to support the beneficial effects of alternatives on production 
performance in broilers. Studies revealed conflicting results; therefore there is still much scope for 
more research and new developments in terms of finding alternative solutions to replace antibiotics in 
feed rations. 
 
In order to be a true alternative to growth promoting antibiotics, the proposed products must show a 
similar mode of action. This is said for some probiotics and prebiotics, herbal extracts and organic and 
inorganic acids. The poultry industry has become aware of the use of probiotics and prebiotics as a 
potential alternative for antibiotics, and it seems to be the most popular candidates in the quest for 
finding alternatives for the use of antimicrobials. However, further insight is needed. 
 
The objective of the study was to evaluate various alternatives, such as garlic, Bio-Mos® and Acid-
Pak 4-way®, in an attempt to find a suitable candidate that can be used as an alternative to antibiotics 
in poultry diets.   
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Chapter 3 
The effect of fresh garlic and Bio-Mos®, a commercial 
prebiotic, on nitrogen (N)-and amino acid digestibilities in 
broilers 
 
3.1 Introduction 
 
The concern surrounding the use of antibiotics as growth promoters in intensive agriculture systems 
has resulted in producers searching for possible alternatives to antibiotics. The suitability of these 
substances as substitutes for antibiotics, and more specifically the effect of these substances have not 
been intensively investigated.  
 
Garlic (Allium sativum) has been prescribed as a traditional medicine for many years. Recent 
investigations have shown several therapeutic and prophylactic properties in garlic (Horton et al., 
1992). Early steps in identifying the active constituents of garlic were the discovery that the compound 
allicin (allyl 2-propene thiosulfinate) is formed when garlic cloves are crushed and that its formation 
depends upon the action of the enzyme aliinase of the bundle sheath cells upon the alliin of mesophyll 
cells (Ross et al., 2001). Mannan oligosaccharides (MOS), for instance Bio-Mos®, are derived from a 
specific strain of yeast. It consists of a mannan and a glucan component. The structure of the mannan 
component resembles that of the carbohydrates on the wall of the intestine. Pathogenic, growth-
inhibiting microbes normally adhere to the mannans on the wall of the intestine, but bind to the 
mannan component of the Bio-Mos® instead. Because these pathogens do not attach to the gut wall, 
they are flushed from the upper gut. Therefore Bio-Mos® plays an essential role in animal nutrition 
and performance in that it prevents pathogens from adhering to the intestinal wall (Sun et al., 2005). In 
poultry Bio-Mos® has a positive effect on flock health and viability, feed efficiency and weight gain, 
profitable egg production, improved chick quality and better meat and egg marketability (Waldroup et 
al., 2003).   
 
The objective of this trial was to evaluate the effect of fresh garlic and Bio-Mos® on apparent nitrogen 
(AND) and amino acid (AAD) digestibilities in broilers, and to compare their effects to that of an 
antibiotic (doxycyclin). 
 
3.2 Materials and methods 
 
One hundred and forty-four day-old female broiler chicks (Cobb 500) were placed in wire-mesh cages 
(three chicks per cage). The experimental units/cages were allocated at random to the 16 (A to P) 
experimental treatments with three replicates per treatment. The birds were vaccinated at day-old 
against Newcastle disease and Infectious bronchitis. The environmental temperature within the house 
was 30°C for the first day and was then decreased by 0.5°C every second day until 20°C was 
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reached. Continuous light (24L:0D) was provided for the duration of the trail. Birds were offered ad 
libitum access to feed and water. The experiment had a completely randomised design with main 
effect of dietary treatment. The three experimental trials were approved by the University of 
Stellenbosch Animal Ethics Committee.  
 
3.3 Experimental design 
 
A starter (0 to 21 days) and a finisher (22 to 35 days) broiler diet were formulated using the EFG 
Broiler Nutrition Optimizer Program (Winfeed 2 Feed Formulator, 2005). The ingredients used in the 
diets, as well as the formulated nutrient composition of the diets are shown in Table 3.1.  
 
Table 3.1. Composition of starter and finisher diets based on as fed basis (g/kg). 
Ingredient Starter Finisher 
 Maize  441.85 587.39 
 Maize gluten 60  19.52 58.52 
 Soybean full fat  50.00 50.00 
 Soybean oil cake meal (46%CP)  382.38 218.38 
 L-lysine HCl  2.06 3.67 
 DL-methionine  1.27 0.85 
 L-threonine  0.13 0.40 
 Choline chloride 60%  1.51 0.51 
 Vit + min premix  1.50 1.50 
 Limestone  16.69 17.70 
 Salt  1.72 1.75 
 Monocalcium phosphate  16.58 16.64 
 Sodium bicarbonate  4.78 2.70 
 Sunflower oil  60.00 40.00 
Calculated nutrient content(*)   
AMEn (MJ/kg) 11.88 13.00 
Crude protein (%) 24.70 20.92 
Lysine (%) 1.52 1.25 
Methionine (%) 0.50 0.44 
Methionine + Cystine (%) 0.91 0.82 
Threonine (%) 0.96 0.82 
Tryptophan (%) 0.29 0.21 
Arginine (%) 1.67 1.24 
Isoleucine (%) 1.14 0.92 
Leucine (%) 2.20 2.19 
Histidine (%) 0.66 0.55 
Phenylalanine (%) 1.17 1.00 
Tyrosine (%) 1.00 0.84 
Phenylalanine + Tyrosine (%) 2.17 1.85 
Valine (%) 1.25 1.05 
Calcium (%) 1.00 1.00 
Available Phosphorus (%) 0.50 0.50 
   
(*) Amino acids expressed on a digestible basis 
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The starter and finisher diets were fed as either mash or pellets. Fresh garlic was included at three 
levels of 8g/kg, 13g/kg and 18g/kg. Bio-Mos® was included at three levels of 1g/kg, 2g/kg and 3g/kg 
for the starter diet, and 0.5g/kg, 1g/kg and 1.5g/kg for the finisher diet. Celite® was included at 20g/kg 
as an indigestible marker in all dietary treatments. The antibiotic, doxycyclin, was added to treatments 
B and D (positive control) at 0.3 g/kg. Treatments A and C were the control diets (negative control). A 
summary of the dietary treatments is shown in Table 3.2.  
 
Table 3.2 A description of the dietary treatments used throughout the trial. 
Treatment Description
A Control diet without antibiotic (mash)  
B Control diet with antibiotic (mash) 
C Control diet without antibiotic (pelleted)  
D Control diet with antibiotic (pelleted) 
E Control + Bio-Mos®  L1 (mash) 
F Control + Bio-Mos®  L2 (mash) 
G Control + Bio-Mos® L3 (mash) 
H Control + Bio-Mos®  L1(pelleted) 
I Control + Bio-Mos®  L2 (pelleted) 
J Control + Bio-Mos® L3 (pelleted) 
K Control + garlic L1(mash) 
L Control + garlic L2 (mash) 
M Control + garlic L3 (mash) 
N Control + garlic L1 (pelleted) 
O Control + garlic L2 (pelleted) 
P Control + garlic L3 (pelleted) 
 
All starter diets were removed on the morning of day 14 and the finisher diets were allocated to the 
respective cages. On the morning of day 21, one bird per cage was stunned and killed by cervical 
dislocation (Ten Doeschate et al., 1993). Immediately after the chickens were killed the stomach was 
opened up and the ileum exposed. A 15cm segment of the gastrointestinal tract (GIT) of the terminal 
ileum, 2cm anterior to the ileo-caecal junction (to avoid contamination with urine), was removed. Each 
segment was emptied by gently squeezing the segment between the thumb and the forefinger so as to 
prevent damage to the intestinal mucosa. After most of the contents have been removed, each 
segment was flushed with distilled water (Ten Doeschate et al., 1993; Sun et al., 2005). Digesta 
samples from individual birds were pooled within a treatment and immediately frozen in a freezer at -
20°C to avoid bacterial contamination of the samples. The samples were then freeze-dried and finely 
ground to pass through a 0.75 mm sieve and then stored at -20°C for later chemical analysis. The 
procedure was repeated on the mornings of day 28 and 35. 
 
Duplicate samples of both dietary treatments and the excreta samples were analyzed for nitrogen (N) 
content with a Leco N analyzer. A Leco N analyzer determines the % N content from a 0.1g sample by 
means of a combustion process (AOAC, 1990). Digesta and feed were hydrolysed for 24 hours with 
6N hydrochloric acid at 110°C. This was done for the determination of AA by HPLC using the Pico-
Tag® system from Waters Chromatography Systems.  
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The apparent ileal digestibity coefficients were calculated for nitrogen (N) and amino acids (AA) using 
the following equations (Ravindran et al., 1999). 
 
Apparent nitrogen digestibility (AND)  
 
AND = (N/AIA)d – (N/AIA)i 
               (N/AIA)d 
 
where  (N/AIA)d = ratio of N to acid-insoluble ash in the diet 
and  (N/AIA)i = ratio of N to acid-insoluble ash in the ileal digesta 
 
Apparent amino acids digestibility (AAD) 
 
AAD = (AA/AIA)d – (AA/AIA)i 
            (AA/AIA)d 
 
where  (AA/AIA)d = ratio of AA to acid-insoluble ash in the diet 
and  (AA/AIA)i = ratio of AA to acid-insoluble ash in the ileal digesta 
 
Levene’s test was used to test for homogeneity of variance and the Kolmogorov-Smirnov test was 
used to test for normal distribution of the data. All data of equal variance and normal distribution were 
analysed by ANOVA using the GLM procedure of SAS Enterprise guide 3.0 (Waldroup et al., 2003; 
Angel et al., 2005). The Bonferroni (Dunn) t-test was used to test for differences between treatment 
means where the treatment effect was found to be significant. The probability level was set at 5%. 
 
3.4. Results and discussion 
 
Results 
 
The results of AND coefficients for the entire experimental period are presented in Table 3.3. At days 
21 and 28 none of the treatments had any significant effect (P=0.207 and P=0.405 respectively) on 
AND. At day 35, the treatments supplemented with garlic (pellet), as well as the highest level Bio-
Mos® (1.5g/kg, mash), showed a negative effect (P<0.0001) on AND, when compared to the rest of 
the treatments. The rest of the treatments showed no significant differences in their effects on AND, 
when compared to the treatments with (positive control) or without (negative control) doxycyclin 
supplementation. The only differences between feeding a mash or pellet were seen with the 
treatments supplemented with garlic at the lowest (8g/kg) and middle (13g/kg) inclusion levels. It 
showed that the pelleted treatments had a negative effect (P<0.0001) on AND.  
 
It can be concluded that none of the treatments improved AND, when compared to the positive or 
negative controls. It seems that feeding a pelleted feed had a negative effect on AND, because the 
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negative effects were more pronounced. The reason for this could be that the temperature involved in 
the pelleting process can have a negative influence on the activity of the products, garlic and Bio-
Mos®.     
 
Table 3.3 Apparent Nitrogen digestibility (AND) coefficients (±SE) for 21, 28 and 35 days. 
Period D21 D28 D35 
Treatment N AND N AND N AND 
C+Ma   2 0.652 (0.109) 2 0.715 (0.020) 2 0.726 (0.004)a
C+Pe  2 0.756 (0.003) 2 0.699 (0.001) 2 0.782 (0.001)a 
C-Ma   2 0.759 (0.004) 2 0.744 (0.026) 2 0.774 (0.001)a 
C-Pe  2 0.715 (0.045) 2 0.723 (0.008) 2 0.698 (0.013)a 
GARL1Ma   2 0.665 (0.032) 2 0.719 (0.017) 2 0.728 (0.004)a 
GARL1Pe   2 0.710 (0.000) 2 0.674 (0.024) 2 0.222 (0.146)c 
GARL2Ma   2 0.592 (0.044) 2 0.600 (0.009) 2 0.680 (0.014)a 
GARL2Pe   2 0.616 (0.018) 2 0.699 (0.027) 2 0.327 (0.027)dc 
GARL3Ma   2 0.562 (0.098) 2 0.742 (0.006) 2 0.180 (0.010)c 
GARL3Pe   2 0.629 (0.056) 2 0.645 (0.050) 2 0.222 (0.007)c 
MOSL1Ma   2 0.706 (0.029) 2 0.639 (0.054) 2 0.734 (0.007) a 
MOSL1Pe   2 0.772 (0.055) 2 0.606 (0.175) 2 0.777 (0.043)a 
MOSL2Ma   2 0.724 (0.008) 2 0.770 (0.011) 2 0.691 (0.022)a 
MOSL2Pe   2 0.732 (0.011) 2 0.706 (0.026) 2 0.729 (0.003)a 
MOSL3Ma   2 0.741 (0.044) 2 0.730 (0.021) 2 0.578 (0.030)ab 
MOSL3Pe   2 0.712 (0.000) 2 0.776 (0.012) 2 0.663 (0.104)a 
P-value1 2 0.207  2 0.405  2 <0.0001  
1 P-value. a-c Means within a column with different superscripts differ significantly 
C+ = positive control; C- = negative control; Ma = mash; Pe = pellets; GAR = garlic; MOS = Bio-Mos®; L = levels 
 
The different treatments were compared to the treatments with (positive control) or without (negative 
control) antibiotic (doxycyclin) supplementation for days 21, 28 and 35. 
 
The AAD at day 21 are presented in Table 3.4. The following significant (P<0.05) differences, between 
treatments, were found. When compared to the negative control (mash), the AAD for glycine improved 
with the treatments that were supplemented with Bio-Mos® (1g/kg, pellet) and garlic (8g/kg, mash). 
The treatment that was supplemented with garlic (13g/kg, pellet) had a negative effect on the AAD for 
three amino acids (tyr, phen and leu) and the treatment with garlic (18g/kg, mash) had a negative 
effect on the AAD for two amino acids (arg, met). When compared to the negative control (pellet), the 
treatment that was supplemented with garlic (18g/kg, mash) had a negative effect on the AAD for 13 
amino acids (ser, arg, val, his, lys, pro, met, tyr, cys, ileu, phen, leu and gly), the treatment with garlic 
(13g/kg, pellet) had a negative effect on the AAD for four amino acids (met, tyr, phen and leu) and the 
treatment with Bio-Mos® (1.5g/kg, pellet) had a negative effect on the AAD for only one amino acid 
(gly). When compared to the positive control (mash), the treatment that was supplemented with garlic 
(18g/kg, mash) had a negative effect on the AAD for 16 amino acids (ala, thr, ser, arg, val, his, asp, 
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lys, pro, met, tyr, cys, ileu, phen, leu and gly), the treatment with garlic (13g/kg, pellet) had a negative 
effect on the AAD for five amino acids (ala, met, tyr, phen and leu) and the treatment with Bio-Mos® 
(1.5g/kg, pellet) had a negative effect on the AAD for one amino acid (gly) . When compared to the 
positive control (pellet), the treatment that was supplemented with garlic (18g/kg, mash) had a 
negative effect on AAD for 10 amino acids (ala, ser, arg, val, his, lys, pro, met, tyr and cys), the 
treatment with garlic (13g/kg, pellet) had a negative effect on the AAD for five amino acids (ala, met, 
tyr, phen and leu) and the treatment with Bio-Mos® (1.5g/kg, pellet) had a negative effect only on 
glycine.  
 
The AAD at day 28 are presented in Table 3.5. The only significant (P<0.05) difference was found 
between the negative control (mash) and the treatments that were supplemented with Bio-Mos® 
(0.5g/kg, pellet) and garlic (13g/kg, mash). These treatments had a negative effect on AAD for glycine, 
when compared to the negative control (mash).  
 
The AAD at day 35 are presented in Table 3.6. The following significant (P<0.05) differences, between 
treatments, were found. When compared to the negative control (mash), the treatment that was 
supplemented with garlic (18g/kg, mash) had a negative effect on the AAD for 16 amino acids (ala, thr, 
ser, arg, glut, val, his, asp, lys, pro, met, tyr, cys, phen, leu and gly). The treatment with garlic (18g/kg, 
pellet) had a negative effect on the AAD for four amino acids (met, tyr, phen and leu). The treatment 
with Bio-Mos® (1.5g/kg, pellet) had a negative effect on the AAD for four amino acids (met, cys, phen 
and gly). The treatment with garlic (8g/kg, pellet) had a negative effect on the AAD for three amino 
acids (tyr, cys and phen), and the treatment with garlic (13g/kg, pellet) had a negative effect on AAD 
for two amino acids (tyr and phen). When compared with the negative control (pellet), the treatment 
that was supplemented with garlic (18g/kg, mash) had a negative effect on the AAD for 16 amino 
acids (ala, thr, ser, arg, glut, val, his, asp, lys, pro, met, tyr, cys, phen, leu and gly), the treatment with 
garlic (18g/kg, pellet) had a negative effect on the AAD for three amino acids (glut, tyr and phen), and 
the treatment with garlic (13g/kg, pellet) and Bio-Mos® (1.5g/kg, pellet) had a negative effect on the 
AAD for amino acid (asp and gly respectively). When compared to the positive control (mash), the 
treatment that was supplemented with garlic (18g/kg, mash) had a negative effect on the AAD for 16 
amino acids (ala, thr, ser, arg, glut, val, his, asp, lys, pro, met, tyr, cys, phen, leu and gly), the 
treatment with garlic (18g/kg, pellet) had a negative effect on the AAD for four amino acids (glut, met, 
tyr and phen), and the treatments with Bio-Mos®  (0.5g/kg, 1g/kg, mash and 0.5g/kg, pellet) and garlic 
(13g/kg. mash) had a negative effect on the AAD for one amino acid (tyr). When compared with the 
positive control (pellet), the treatment that was supplemented with garlic (18g/kg, mash) had a 
negative effect on the AAD for all 17 amino acids, the treatment with garlic (18g/kg, pellet) had a 
negative effect on the AAD for four amino acids (glut, met, tyr and phen), the treatment with Bio-Mos® 
(1.5g/kg, pellet) had a negative effect on the AAD for four amino acids (met, ileu, phen and gly), the 
treatment with garlic (13g/kg, pellet) had a negative effect on the AAD for three amino acids (asp, tyr 
and phen), and the treatment with garlic (8g/kg, pellet) had a negative effect on the AAD for two amino 
acids (tyr, phen). 
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Discussion 
 
In general most of the treatments did not show any improvement in AAD at any determination period 
(day 21, 28 or 35). Yang et al., (2008) supported similar results by proving that Bio-Mos® had no 
effect on apparent total tract digestibility of nutrients. The lack of response could be the result of the 
absence of any real health challenge for the birds or the facilities were too clean. At day 21 and day 
35, the diet supplemented with 18g/kg garlic (mash) has shown to have a negative effect on AAD, 
when compared to the negative and positive control. Some opposing results from Adibmoradi et al 
(2006) found that garlic meal, as a feed additive in chickens, resulted in some small intestinal 
morphological changes (enhanced villus height and crypt depth, decreased epithelial thickness), which 
in turn demonstrate that absorptive process could be activated. Sarica et al (2005) found that 
supplementation with garlic increased the length of the small intestine. This can have a positive 
influence on digestibility of nutrients. Yang et al (2007) also observed a numerical increase in the 
digestibility of nutrients in the small intestine in the young birds, when fed Bio-Mos® diets. It doesn’t 
seem that feeding either a mash or a pellet had an influence on the effects exerted by the different 
treatments.  
 
3.5 Conclusions 
 
Besides statistical proof that garlic has no beneficial effects on AAD and AND, it is also a very 
unpractical alternative. There is the risk of destroying the active ingredient, allicin, with exposure to 
high temperatures. Therefore, the garlic needs to be freeze-dried. Freeze-drying is a much more 
cumbersome and more complicated process of removing moisture than oven-drying. Because garlic 
mainly constitutes moisture, an enormous amount of the weight of the garlic gets lost in the drying 
process. Therefore one needs to include much more fresh garlic, in order to get the correct weight of 
dry product needed. Its hygroscopic nature (tendency to retain moisture and form lumps), is another 
unattractive characteristic of garlic. This makes it difficult to store and be mixed with other feed 
ingredients, in other words processed. 
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Table 3.4 Mean apparent digestibility coefficients (±SE) for individual amino acids in broiler chickens on a diet supplemented with either garlic or Bio-Mos® at 21 
days. 
Treatment 
Amino acid C-Ma C+Ma C-Pe C+Pe MOSL1Ma MOSL2Ma MOSL3Ma MOSL1Pe P-value 
Alanine 0.823 (0.050)abc 0.914 (0.002) a 0.866 (0.003) abc 0.917 (0.014) a 0.863 (0.015) abc 0.883 (0.001) ab 0.923 (0.012) a 0.861 (0.034) abc 0.0004 
Threonine 0.761 (0.068) abc 0.880 (0.002) ab 0.873 (0.003) abc 0.821 (0.029) abc 0.875 (0.014) abc 0.750 (0.002) abc 0.914 (0.014) a 0.830 (0.041) abc 0.0002 
Serine 0.787 (0.061) abc 0.881 (0.002) ab 0.872 (0.003)ab 0.897 (0.017) ab 0.820 (0.020) ab 0.845 (0.001) ab 0.927 (0.011) a 0.852 (0.036) a 0.0006 
Arginine 0.969 (0.009) a 0.977 (0.000) a 0.965 (0.001)a 0.975 (0.004) a 0.951 (0.005) a 0.958 (0.000) a 0.982 (0.003) a 0.957 (0.011) a 0.0002 
Glutamic acid 0.878 (0.035) ab 0.909 (0.002) ab 0.864 (0.003) ab 0.896 (0.017) ab 0.900 (0.011) ab 0.896 (0.001) ab 0.954 (0.007) a 0.882 (0.029) ab 0.0029 
Valine 0.792 (0.059) abc 0.890 (0.002) ab 0.851 (0.004)ab 0.896 (0.017) ab 0.826 (0.019) ab 0.842 (0.001) ab 0.923 (0.012) a 0.823 (0.043) ab 0.0010 
Histidine 0.838 (0.046) ab 0.937 (0.001) a 0.917 (0.002) a 0.939 (0.010) a 0.895 (0.012) ab 0.894 (0.001) ab 0.913 (0.014) a 0.890 (0.0027) ab 0.0018 
Aspartic acid 0.765 (0.067) ab 0.822 (0.004) ab 0.807 (0.005) ab 0.827 (0.028) ab 0.826 (0.019) ab 0.806 (0.002) ab 0.939 (0.010) a 0.800 (0.048) ab 0.0054 
Lysine 0.895 (0.030) ab 0.923 (0.002) a 0.911 (0.002) a 0.929 (0.012) a 0.904 (0.011) a 0.899 (0.001) ab 0.964 (0.006) a 0.896 (0.025) ab 0.0025 
Proline 0.823 (0.050) abc 0.896 (0.002) ab 0.852 (0.004) ab 0.894 (0.017) ab 0.841 (0.018) abc 0.855 (0.000) abc 0.947 (0.008) a 0.860 (0.034) abc 0.0010 
Methionine 0.952 (0.014) ab 0.961 (0.001) a 0.909 (0.002) a 0.937 (0.010) ab 0.915 (0.009) ab 0.949 (0.000) ab 0.972 (0.004) a 0.936 (0.016) ab <0.0001 
Tyrosine 0.855 (0.041) abc 0.912 (0.002) ab 0.845 (0.004) ab 0.891 (0.018) ab 0.884 (0.013) ab 0.891 (0.001) ab 0.954 (0.007)a 0.850 (0.036) abc <0.0001 
Cysteine 0.943(0.016) ab 0.976 (0.000) a 0.974 (0.001) a 0.977 (0.004) a 0.965 (0.004) ab 0.965 (0.000) ab 0.976 (0.004) a 0.953 (0.011) ab 0.0035 
Isoleucine 0.841 (0.045) abc 0.901 (0.002) ab 0.840 (0.004) ab 0.877 (0.020) abc 0.848 (0.017) abc 0.854 (0.001) abc 0.929 (0.011) a 0.838 (0.039) abc 0.0027 
Phenylalanine 0.911 (0.025) ab 0.932 (0.001) a 0.889 (0.003) a 0.907 (0.015) ab 0.905 (0.011) ab 0.882 (0.001) abc 0.951 (0.008) a 0.870 (0.031) abc 0.0005 
Leucine 0.910 (0.026) ab 0.937 (0.001) a 0.890 (0.003) a 0.922 (0.013) ab 0.915 (0.010) ab 0.899 (0.001) abc 0.954 (0.007) a 0.904 (0.023) abc 0.0003 
Glycine 0.736 (0.075) bcde 0.905 (0.002) abc 0.887 (0.003) abc 0.847 (0.025) abcd 0.898 (0.011) abcd 0.720 (0.002) cde 0.894 (0.017) abcd 0.810 (0.046) abcde <0.0001 
Amino acid 
                
MOSL2Pe 
MOSL3Pe GARL1Ma GARL2Ma GARL3Ma GARL1Pe GARL2Pe GARL3Pe P-value 
Alanine 0.837 (0.003) abc 0.788 (0.012) abc 0.887 (0.009) a 0.904 (0.009) a 0.703 (0.070) c 0.853 (0.000) abc 0.717 (0.015) bc 0.855 (0.018) abc 0.0004 
Threonine 0.934 (0.001) a 0.681 (0.018) bc 0.939 (0.005) a 0.893 (0.010) a 0.673 (0.077) c 0.771 (0.000) abc 0.906 (0.005) a 0.748 (0.031) abc 0.0002 
Serine 0.833 (0.003) ab 0.810 (0.011) abc 0.894 (0.008) ab 0.874 (0.012) ab 0.598 (0.095) c 0.817 (0.000) ab 0.704 (0.016) bc 0.806 (0.024) abc 0.0006 
Arginine 0.941 (0.001) ab 0.968 (0.002) a 0.969 (0.002) a 0.960 (0.004) a 0.893 (0.025) b 0.969 (0.000) a 0.945 (0.003) a 0.976 (0.003) a 0.0002 
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Glutamic acid 0.881 (0.002) ab 0.822 (0.010) b 0.900 (0.008) ab 0.902 (0.009) ab 0.812 (0.044) b 0.893 (0.000) ab 0.801 (0.012) b 0.852 (0.018) ab 0.0029 
Valine 0.823 (0.003) ab 0.769 (0.013) abc 0.844 (0.012) ab 0.850 (0.014) ab 0.617 (0.090) c 0.805 (0.000) abc 0.685 (0.017) bc 0.800 (0.025) abc 0.0010 
Histidine 0.896 (0.002) ab 0.855 (0.008) ac 0.920 (0.006) a 0.925 (0.007) a 0.755 (0.058) b 0.882 (0.000) ab 0.821 (0.009) ab 0.856 (0.018) ab 0.0018 
Aspartic acid 0.859 (0.002) ab 0.728 (0.015) ab 0.878 (0.009) a 0.868 (0.012) ab 0.662 (0.080)b 0.833 (0.000) ab 0.744 (0.014) ab 0.800 (0.025) ab 0.0054 
Lysine 0.905 (0.002) a 0.872 (0.007) ab 0.917 (0.006) a 0.909 (0.008) a 0.784 (0.051) b 0.900 (0.000) ab 0.853 (0.008) ab 0.882 (0.015) ab 0.0025 
Proline 0.858 (0.002) abc 0.784 (0.012) ab 0.887 (0.009) ab 0.897 (0.010) ab 0.707 (0.069) c 0.844 (0.000) abc 0.737 (0.014) bc 0.847 (0.019) abc 0.0010 
Methionine 0.894 (0.002) ab 0.854 (0.008) abc 0.934 (0.005) ab 0.956 (0.004) ab 0.783(0.051) cd 0.946 (0.000) ab 0.754 (0.013) d 0.873 (0.016) abc <0.0001 
Tyrosine 0.828 (0.003) abc 0.816 (0.010) bcd 0.830 (0.013) abc 0.839 (0.015) abc 0.680 (0.075) cd 0.809 (0.000) acdb 0.641 (0.019) d 0.749 (0.031) bcd <0.0001 
Cysteine 0.968 (0.001) ab 0.943 (0.003) abcd 0.966 (0.003) ab 0.968 (0.003) ab 0.919 (0.019) b 0.949 (0.000) ab 0.945 (0.003) ab 0.952 (0.006) ab 0.0035 
Isoleucine 0.857 (0.002) abc 0.794 (0.011)ab 0.871 (0.010) abc 0.851 (0.014) abc 0.708 (0.070) c 0.807 (0.000) abc 0.731 (0.014) bc 0.816 (0.023) abc 0.0027 
Phenylalanine 0.895 (0.002) abc 0.858 (0.008) abc 0.917 (0.006) a 0.883 (0.011) abc 0.790 (0.050) bc 0.865 (0.000) abc 0.777 (0.012) c 0.844 (0.019) abc 0.0005 
Leucine 0.906 (0.002) abc 0.876 (0.007) abc 0.926 (0.006) a 0.913 (0.008) abc 0.817 (0.043) bc 0.893 (0.000) abc 0.789 (0.011) c 0.877 (0.015) abc 0.0003 
Glycine 0.837 (0.001) a 0.788 (0.021) e 0.887 (0.004) a 0.904 (0.008) abc 0.703 (0.072) ed 0.777 (0.000) abcde 0.717 (0.003) ab 0.855 (0.030) abcde <0.0001 
a-e  Means within a row with different superscripts are significantly different 
C+ = positive control; C- = negative control; Ma = mash; Pe = pellets; GAR = garlic; MOS = Bio-Mos®; L = levels 
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Table 3.5 Mean apparent digestibility coefficients (±SE) for individual amino acids in broiler chickens on a diet supplemented with either garlic or Bio-Mos® at 28 
days. 
Treatment 
Amino acid C-Ma C+Ma C-Pe C+Pe MOSL1Ma MOSL2Ma MOSL3Ma MOSL1Pe P-value 
Alanine 0.780 (0.042)  0.853 (0.002) 0.819(0.015)  0.832 (0.018) 0.748 (0.079)  0.789 (0.073) 0.881 (0.011)  0.268 (0.432) 0.2431 
Threonine 0.895 (0.021)  0.856 (0.032)  0.828 (0.037) 0.713 (0.095) 0.683 (0.078)  0.805 (0.007) 0.832 (0.047)  0.453 (0.279) 0.1835 
Serine 0.713 (0.062)  0.739 (0.077)  0.716 (0.125) 0.767 (0.076) 0.599 (0.211)  0.786 (0.059) 0.812 (0.086)  0.264 (0.490) 0.7667 
Arginine 0.773 (0.161)  0.661 (0.235)  0.809 (0.135) 0.656 (0.257) 0.696 (0.191) 0.811 (0.116) 0.884 (0.091)  0.647 (0.288)  0.9728 
Glutamic acid 0.316 (0.603)  0.618 (0.305)  0.275 (0.594) 0.302 (0.594) 0.196 (0.698) 0.533 (0.390) 0.524 (0.412) -0.192 (1.094)  0.9984 
Valine 0.887 (0.033) 0.899 (0.035)  0.894 (0.033) 0.901 (0.021) 0.869 (0.025) 0.899 (0.035) 0.903 (0.011) 0.780 (0.010) 0.1196 
Histidine 0.770 (0.003)  0.801 (0.015)  0.769 (0.031) 0.785 (0.055) 0.759 (0.033) 0.779 (0.006) 0.828 (0.051) 0.523 (0.179)  0.0660 
Aspartic acid 0.432 (0.417)  0.438 (0.418)  0.318 (0.515) 0.299 (0.560) 0.208 (0.639) 0.463 (0.399) 0.662 (0.252) -0.525 (1.367)  0.9629 
Lysine 0.909 (0.026)  0.921 (0.012)  0.913 (0.024) 0.917 (0.026) 0.886 (0.036) 0.923 (0.016) 0.905 (0.044) 0.842 (0.082) 0.2001 
Proline 0.825 (0.052)  0.881 (0.026)  0.798 (0.054) 0.825 (0.063) 0.785 (0.076) 0.857 (0.024) 0.852 (0.074) 0.547 (0.245) 0.5021 
Methionine 0.968 (0.013)  0.968 (0.015) 0.953 (0.026) 0.957 (0.022) 0.967 (0.012) 0.970 (0.013) 0.970 (0.009) 0.934 (0.003) 0.9863 
Tyrosine 0.358 (0.577)  0.580 (0.357) 0.464 (0.436) 0.320 (0.600) 0.589 (0.342) 0.535 (0.405) 0.372 (0.534) 0.134 (0.802) 0.9604 
Cysteine 0.896 (0.052)  0.945 (0.031) 0.838 (0.093) 0.875 (0.080) 0.860 (0.089) 0.824 (0.092) 0.838 (0.129) 0.875 (0.085) 0.7263 
Isoleucine 0.721 (0.171)  0.721 (0.179) 0.606 (0.257) 0.626 (0.251) 0.591 (0.271) 0.712 (0.180) 0.779 (0.121) 0.283 (0.550) 0.9529 
Phenylalanine 0.888 (0.078)  0.908 (0.035) 0.855 (0.053)  0.858 (0.063) 0.839 (0.075) 0.884 (0.035) 0.857 (0.074) 0.748 (0.162) 0.4085 
Leucine 0.817 (0.027)  0.836 (0.078) 0.799 (0.055)  0.803 (0.007) 0.801 (0.030) 0.777 (0.045)  0.528 (0.181) 0.820 (0.031) 0.2550 
Glycine 0.926 (0.078) a 0.906 (0.004) ab 0.888 (0.004) ab 0.841 (0.013) ab 0.769 (0.022) ab 0.828 (0.044) ab 0.829 (0.022) ab 0.681 (0.075) ab 0.0031  
Amino acid MOSL2Pe MOSL3Pe GARL1Ma GARL2Ma GARL3Ma GARL1Pe GARL2Pe GARL3Pe P-value 
Alanine 0.798 (0.008) 0.808 (0.055) 0.719 (0.017) 0.784 (0.035)  0.840 (0.000) 0.825 (0.023)  0.780 (0.026)  0.868 (0.029) 0.2431 
Threonine 0.807 (0.014) 0.822 (0.001) 0.613 (0.105) 0.438 (0.246)  0.721 (0.000)  0.780 (0.004)  0.778 (0.006)  0.831 (0.029)  0.1835 
Serine 0.591 (0.246)  0.854 (0.030) 0.160 (0.570) 0.362 (0.358)  0.767 (0.000)  0.747 (0.049)  0.417 (0.375)  0.787 (0.062)  0.7667 
Arginine 0.863 (0.074)  0.898 (0.073) 0.657 (0.253)  0.503 (0.356)  0.918 (0.000)  0.837 (0.102)  0.844 (0.082)  0.829 (0.137)  0.9728 
Glutamic acid 0.547 (0.357)  0.332 (0.575) -0.269 (1.038) -0.334 (1.166)  0.896 (0.000)  0.171 (0.724)  0.085 (0.772)  0.390 (0.507)  0.9984 
Valine 0.885 (0.053) 0.914 (0.041) 0.744 (0.057) 0.812 (0.025)  0.833 (0.000)  0.881 (0.043)  0.874 (0.053)  0.905 (0.023)  0.1196 
Histidine 0.791 (0.011) 0.852 (0.010) 0.715 (0.003)  0.694 (0.047) 0.795 (0.000)  0.846 (0.026) 0.829 (0.028)  0.851 (0.000)  0.0660 
Aspartic acid 0.514 (0.393) 0.491 (0.400) -0.873 (1.582)  -0.918 (1.705)  0.825 (0.000)  0.295 (0.570)  0.371 (0.483) 0.435 (0.453) 0.9629 
Lysine 0.926 (0.011)  0.939 (0.006) 0.746 (0.074)  0.808 (0.079)  0.918 (0.000)  0.914 (0.019)  0.908 (0.015)  0.916 (0.020)  0.2001 
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Proline 0.852 (0.026)  0.876 (0.018)  0.658 (0.122) 0.679 (0.144)  0.864 (0.000)  0.821 (0.040) 0.797 (0.041)  0.848 (0.064) 0.5021 
Methionine 0.955 (0.025)  0.965 (0.020) 0.963 (0.019) 0.945 (0.012)  0.960 (0.000) 0.957 (0.022) 0.937 (0.042)  0.963 (0.019) 0.9863 
Tyrosine 0.590 (0.293) 0.649 (0.270) -0.908 (1.553)  -0.379 (1.213)  0.915 (0.000) 0.196 (0.667) 0.514 (0.307) 0.561 (0.315) 0.9604 
Cysteine 0.868 (0.055) 0.896 (0.043) 0.582 (0.223)  0.730 (0.156) 0.930  0.000) 0.846 (0.056) 0.882 (0.041) 0.876 (0.043) 0.7263 
Isoleucine 0.651 (0.220) 0.744 (0.145) 0.135 (0.545)  0.253 (0.539) 0.869 (0.000) 0.660 (0.194) 0.579 (0.258) 0.678 (0.206) 0.9529 
Phenylalanine 0.850 (0.046) 0.876 (0.039) 0.568 (0.162)  0.708 (0.124)  0.905 (0.000) 0.860 (0.035) 0.816 (0.032) 0.852 (0.046)  0.4085 
Leucine 0.727 (0.086) 0.808 (0.045) 0.518 (0.159) 0.627 (0.054)  0.740 (0.000) 0.663 (0.126)  0.776 (0.064) 0.753 (0.060)  0.2550 
Glycine 0.798 (0.031) a 0.808 (0.034)a 0.719 (0.030) a b 0.784 (0.076) b  0.765 (0.000) ab 0.825 (0.039) ab 0.780 (0.027) ab 0.868 (0.005) ab 0.0031  
a-b  Means within a row with different superscripts are significantly different 
C+ = positive control; C- = negative control; Ma = mash; Pe = pellets; GAR = garlic; MOS = Bio-Mos®; L = levels 
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Table 3.6 Mean apparent digestibility coefficients (±SE) for individual amino acids in broiler chickens on a diet supplemented with either garlic or Bio-Mos® at 35 d. 
Treatment 
Amino acid C-Ma C+Ma C-Pe C+Pe MOSL1Ma MOSL2Ma MOSL3Ma MOSL1Pe P-value 
Alanine 0.803 (0.002) a 0.881 (0.002) a 0.899 (0.007) a 0.867 (0.001) a 0.857 (0.004) a 0.822 (0.007) a 0.701 (0.023) a 0.847 (0.035) a <0.0001 
Threonine 0.801 (0.003) a 0.830 (0.002) a 0.875 (0.006) a 0.883 (0.001) a 0.821 (0.006) a 0.741 (0.011) a 0.681 (0.024) a 0.835 (0.038) a <0.0001 
Serine 0.793 (0.002) a 0.869 (0.002) a 0.888 (0.006) a 0.879 (0.001) a 0.819 (0.006) a 0.826 (0.007) a 0.756 (0.018) a 0.898 (0.023) a <0.0001 
Arginine 0.978 (0.001) a 0.968 (0.000) a 0.971 (0.003) a 0.950 (0.000) a 0.897 (0.003) a 0.934 (0.003) a 0.930 (0.005) a 0.963 (0.009) a <0.0001 
Glutamic acid 0.905 (0.001) a 0.925 (0.001) a 0.933 (0.005) a 0.903 (0.000) a 0.929 (0.002) a 0.929 (0.003) a 0.866 (0.010) a 0.932 (0.016) a <0.0001 
Valine 0.839 (0.002) a 0.879 (0.001) a 0.906 (0.006) a 0.886 (0.001) a 0.865 (0.004) a 0.836 (0.007) a 0.746 (0.019) a 0.842 (0.036) a <0.0001 
Histidine 0.812 (0.002) a 0.890 (0.002) a 0.895 (0.005) a 0.896 (0.001) a 0.890 (0.003) a 0.872 (0.005) a 0.851 (0.011) a 0.889 (0.025) a <0.0001 
Aspartic acid 0.839 (0.002) ab 0.850 (0.001) ab 0.870 (0.007) a 0.867 (0.001) a 0.881 (0.004) a 0.869 (0.005) a 0.848 (0.011) a 0.882 (0.027) a <0.0001 
Lysine 0.931 (0.001) a 0.942 (0.001) a 0.933 (0.003) a 0.948 (0.000) a 0.944 (0.002) a 0.939 (0.002) a 0.904 (0.007) ab 0.941 (0.014) a <0.0001 
Proline 0.854 (0.002) a 0.901 (0.001) a 0.905 (0.006) a 0.889 (0.001) a 0.892 (0.003) a 0.861 (0.006) a 0.808 (0.014) a 0.888 (0.026) a <0.0001 
Methionine 0.947 (0.001) a 0.964 (0.000) ab 0.964 (0.003) abc 0.934 (0.000) a 0.937 (0.002) abc 0.947 (0.002) ab 0.894 (0.008) abcd 0.948 (0.012) abc <0.0001 
Tyrosine 0.928 (0.001) a 0.954 (0.001) b 0.903 (0.003) a 0.942 (0.001) a 0.942 (0.002) a 0.935 (0.003) a 0.841 (0.012) abc 0.938 (0.014) a <0.0001 
Cysteine 0.928 (0.0000 a  0.975 (0.001) ab 0.958 (0.003) ab 0.948 (0.000) ab 0.959 (0.001) ab 0.959 (0.002) ab 0.930 (0.005) ab 0.947 (0.012) ab <0.0001 
Isoleucine 0.886 (0.002) ab 0.904 (0.001) ab 0.926 (0.005) ab 0.897 (0.000) a 0.885 (0.004) ab 0.877 (0.005) ab 0.757 (0.018) ab 0.883 (0.027) ab <0.0001 
Phenylalanine 0.936 (0.001) a 0.946 (0.001) ab 0.955 (0.003) ab 0.934 (0.000) a 0.934 (0.002) ab 0.910 (0.004) ab 0.849 (0.011) abc 0.933 (0.015) ab <0.0001 
Leucine 0.918 (0.001) a 0.933 (0.001) ab 0.922 (0.004) ab 0.921 (0.000) ab 0.924 (0.002) ab 0.887 (0.005) ab 0.831 (0.013) ab 0.930 (0.016) ab <0.0001 
Glycine 0.803 (0.002) a 0.861 (0.002) ab 0.851 (0.005) a 0.903 (0.001) a 0.833 (0.005) a 0.709 (0.012) ab 0.681 (0.024) ab 0.776 (0.052) ab <0.0001 
Amino acid MOSL2Pe MOSL3Pe GARL1Ma GARL2Ma GARL3Ma GARL1Pe GARL2Pe GARL3Pe P-value 
Alanine 0.785 (0.003) a 0.763 (0.105) a 0.869 (0.005) a 0.847 (0.006) a 0.406 (0.105) b 0.686 (0.035) a 0.684 (0.003) a 0.880 (0.012) a <0.0001 
Threonine 0.770 (0.003) a 0.698 (0.134) a 0.834 (0.006) a 0.839 (0.006) a 0.187 (0.144) b 0.627 (0.041) a 0.594 (0.003) a 0.696 (0.000) a <0.0001 
Serine 0.782 (0.003) a 0.816 (0.082) a 0.872 (0.005) a 0.863 (0.005) a 0.250 (0.133) b 0.730 (0.030) a 0.692 (0.002) a 0.781 (0.000) a <0.0001 
Arginine 0.866 (0.002) a 0.945 (0.024) a 0.948 (0.002) a 0.958 (0.002) a 0.575 (0.075) b 0.916 (0.009) a 0.872 (0.001) a 0.954 (0.000) a <0.0001 
Glutamic acid 0.885 (0.002) a 0.894 (0.047) a 0.912 (0.003) a 0.929 (0.003) a 0.742 (0.046) b 0.839 (0.018) a 0.825 (0.001) a 0.676 (0.000) b <0.0001 
Valine 0.809 (0.003) a 0.766 (0.103) a 0.836 (0.006) a 0.829 (0.006) a 0.366 (0.112) b 0.670 (0.037) a 0.711 (0.002) a 0.831 (0.000) a <0.0001 
Histidine 0.819 (0.003) a 0.855 (0.064) a 0.841 (0.006) a 0.844 (0.006) a 0.443 (0.098) b 0.763 (0.026) a 0.723 (0.002) a 0.706 (0.000) a <0.0001 
Aspartic acid 0.876 (0.002) a 0.847 (0.068) ab 0.888 (0.004) a 0.889 (0.004) a 0.489 (0.090) c 0.784 (0.024) ab 0.786 (0.002) b 0.666 (0.000) ab <0.0001 
Lysine 0.917 (0.001) ab 0.916 (0.037) ab 0.931 (0.002) a 0.940 (0.002) a 0.720 (0.049) c 0.884 (0.013) ab 0.882 (0.001) ab 0.820 (0.000) ab <0.0001 
Proline 0.827 (0.003) a 0.823 (0.078) a 0.888 (0.004) a 0.896 (0.004) a 0.574 (0.075) b 0.755 (0.027) a 0.744 (0.002) a 0.820 (0.000) a <0.0001 
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Methionine 0.940 (0.001) abc 0.917 (0.037) bcd 0.947 (0.002) ab 0.954 (0.002) ab 0.853 (0.026) d 0.902 (0.011) abc 0.897 (0.001) abcd 0.867 (0.000) cd <0.0001 
Tyrosine 0.882 (0.002) ab 0.896 (0.046) abc 0.880 (0.004) ab 0.894 (0.004) a 0.678 (0.057) d 0.732 (0.023) bc 0.764 (0.002) bc 0.736 (0.000) cd <0.0001 
Cysteine 0.909 (0.001) ab 0.885 (0.051) b 0.952 (0.002) ab 0.942 (0.002) ab 0.671 (0.058) c 0.818 (0.020) b 0.855 (0.001) ab 0.872 (0.000) ab <0.0001 
Isoleucine 0.839 (0.002) ab 0.799 (0.089) b 0.863 (0.005) ab 0.853 (0.005) ab 0.552 (0.079) cb 0.696 (0.034) ab 0.751 (0.002) ab 0.781 (0.000) ab <0.0001 
Phenylalanine 0.880 (0.002) abc 0.865 (0.060) bc 0.908 (0.003) ab 0.893 (0.004) ab 0.698 (0.053) d 0.776 (0.025) bc 0.801 (0.002) bc 0.753 (0.000) cd <0.0001 
Leucine 0.884 (0.002) ab 0.874 (0.056) ab 0.912 (0.003) ab 0.902 (0.004) ab 0.715 (0.050) c 0.800 (0.022) ab 0.805 (0.001) ab 0.795 (0.000) b <0.0001 
Glycine 0.773 (0.003) ab 0.637 (0.161) b 0.828 (0.006) a 0.805 (0.007) ab  0.253 (0.132) c 0.544 (0.051) ab 0.636 (0.003) ab 0.709 (0.000) a <0.0001 
a-d  Means within a row with different superscripts are significantly different 
C+ = positive control; C- = negative control; Ma = mash; Pe = pellets; GAR = garlic; MOS = Bio-Mos®; L = levels 
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Chapter 4 
The effect of addition of Bio-Mos®, Acid-Pak 4-way® and MCT 
on nitrogen (N)- and amino acid digestibilities in broilers 
 
4.1. Introduction 
 
From Trial 1 the conclusion was that garlic, as well as Bio-Mos® had no beneficial effects on AND and AAD 
in broilers. It was found that feeding a mash or a pellet did not have any significant effect on AND or AAD. It 
was also concluded from the previous trial that garlic was a very unattractive alternative, due to the difficulty 
of being handled and processed. Bio-Mos® is already a commercially accepted product, therefore it was 
decided to use it again in Trial 2. Bio-Mos® and two substances, Acid-Pak 4-way® (Alltech) and a medium-
chain triglyceride, MCT (Aveve, Belgium) were used and evaluated in terms of their effects on AND and 
AAD. 
 
Acid-Pak 4-way® is a blend of organic acids (i.e. citric acid and sorbic acids), probiotics (beneficial bacteria 
such as Lactobacillus and Streptococcus) and electrolytes. It lowers the pH in the crop (in the absence of 
any feed) and allows lactic acid producing organisms’ passage through the intestinal tract, while 
discouraging the passage of pathogenic bacteria which prefer higher pH. The most effective way to use this 
product is addition to the drinking water (0.5g/l water), but due to the difficulty regarding determination of 
intake, it was included in the feed instead (Sun et al., 2005). Medium-chain triglycerides (MCT) have fatty 
acids 6 to 12 carbon atoms long (Lee & Chiang, 1994). Medium-chain fatty acids are more easily digested 
and absorbed than long-chain fatty acids. Synthetic sources of medium-chain fatty acids have been reported 
to improve overall growth of the chick after the first few weeks post-hatch (Turner et al., 1999).  
 
The aim of this trial was to evaluate the effect of Bio-Mos®, Acid-Pak 4-way® and MCT on AND and AAD in 
broilers, and to compare their effects to that of an antibiotic (doxycyclin).  
 
4.2. Materials and methods 
 
Two hundred and sixty four day-old female Cobb 500 broiler chicks were placed in wire-mesh cages (six 
chicks per cage). The experimental units/cages were allocated at random to the 11 (A to K) experimental 
treatments with four replicates per treatment. The birds were vaccinated at day-old against Newcastle 
disease and Infectious bronchitis. The environmental temperature within the house was 30°C for the first day 
and was then decreased by 0.5°C every second day until 20°C was reached. Continuous light (24L:0D) was 
provided for the duration of the trail. Birds were offered ad libitum access to feed and water. The experiment 
had a completely randomised design with main effect of dietary treatment. The three experimental trials were 
approved by the University of Stellenbosch Animal Ethics Committee.  
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4.3 Experimental design 
 
Starter (0-14 days) and a finisher (15-35 days) broiler diets were formulated with the EFG Broiler Nutrition 
Optimizer Program (Winfeed 2 Feed Formulator, 2005). A detailed list of the ingredients used in the diets 
and the formulated nutrient composition of the diets are shown in Table 4.1. The starter and finisher diets 
were fed as mash.  
 
Table 4.1. Composition of starter and finisher diets for broiler chickens based on as fed basis (g/kg). 
Ingredient Starter Finisher 
Maize 549.85 708.73 
Soybean oil cake meal (46%) 270 251.34 
Soybean full fat 125.23  
Choline chloride 60% 0.67 0.53 
DL-methionine 2.36 1.34 
L-threonine 0.03  
L-lysine HCL 7.68 1.46 
Limestone 21.69 18.13 
Salt 4.03 4.07 
Monocalcium phosphate 11.78 7.41 
Sodium bicarbonate 4.08 4.18 
Vitamin E  0.40 
Vit + min premix 0.50 1.3 
Calculated nutrient content (*)   
AMEn (MJ/kg) 12.49 12.68 
Crude protein (%) 22.00 17.50 
Lysine (%) 1.27 0.95 
Methionine (%) 0.56 0.41 
Methionine + Cystine (%) 0.93 0.72 
Threonine (%) 0.88 0.69 
Tryptophan (%) 0.27 0.20 
Arginine (%) 1.51 1.12 
Isoleucine (%) 1.00 0.79 
Leucine (%) 1.95 1.65 
Histidine (%) 0.62 0.50 
Phenylalanine + tyrosine (%) 1.88 1.51 
Valine (%) 1.05 0.84 
Calcium  1.10 0.90 
Total Phosphorous 0.67 0.54 
(*) Amino acids expressed on a digestible basis.  
AMEn: nitrogen corrected Apparent Metabolisable Energy 
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Bio-Mos® was included at 1g/kg, 2g/kg, and 3g/kg for the starter diet, and at 0.5g/kg, 1g/kg, 1.5g/kg for the 
finisher diet. Acid-Pak 4-way® was included at 0.4g/kg, 1g/kg and 1.6g/kg for both the starter and finisher 
diets. The MCT was included at 3g/kg, 3.6g/kg, 4.2g/kg for the starter diet and 2.1g/kg, 2.7g/kg and 3.4g/kg 
for the fisher diet. The antibiotic was added to the control at 0.3g/kg. Celite® was included at 20g/kg as an 
indigestible marker in all dietary treatments. A summary of the dietary treatments is shown in Table 4.2.  
 
Table 4.2.  Dietary treatments used throughout the trial. 
Treatment Description
A Control + Bio-Mos®  L1  
B Control + Bio-Mos®  L2  
C Control + Bio-Mos®  L3  
D Acid-Pak 4way L1 
E Acid-Pak 4way L2 
F Acid-Pak 4way L3 
G MCT L1 
H MCT L2 
I MCT L3 
J Control diet without antibiotic   
K Control diet with antibiotic  
 
All starter diets were removed on the morning of day 14 and the finisher diets were allocated to the 
respective cages. On the morning of day 21, one bird per cage was stunned and killed by cervical dislocation 
(Ten Doeschate et al., 1993). Immediately after the chickens were killed the stomachs were opened up and 
the ileum exposed. A 15cm segment of the terminal ileum, 2cm anterior to the ileo-caecal junction (to avoid 
contamination with urine), was removed. The segment was emptied by gently squeezing the segment 
between the thumb and the forefinger so as to prevent damage to the intestinal mucosa. After most of the 
contents have been removed, each segment was flushed with distilled water (Ten Doeschate et al.,1993; 
Sun et al., 2005). Digesta samples from individual birds were pooled within a treatment and immediately 
frozen at -20°C to avoid bacterial contamination of the samples. The samples were then freeze-dried and 
finely ground to pass through a 0.75 mm sieve. It was then stored at -20°C awaiting chemical analysis. The 
procedure was repeated on the mornings of day 28 and 35. 
 
Duplicate samples of both the dietary treatments and the excreta samples were analyzed for N content with 
a Leco N analyses. A Leco N analyzer determines the % N content from a 0.1g sample by means of a 
combustion process (AOAC, 1990). The digesta and the feed were hydrolysed for 24 hours with 6N 
hydrochloric acid at 110Cº. This was done for determination of amino acids (AA) by HPLC using the Pico-
Tag system from Waters Chromatography Systems.  
 
Apparent excreta digestibity coefficients for N and AA were calculated using the following equations 
(Ravindran et al., 1999). 
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Apparent nitrogen digestibility (AND)  
 
AND = (N/AIA)d – (N/AIA)i 
               (N/AIA)d 
 
where  (N/AIA)d = ratio of N to acid-insoluble ash in the diet 
and  (N/AIA)i = ratio of N to acid-insoluble ash in the ileal digesta 
 
Apparent amino acid digestibility (AAD) 
 
AAD = (AA/AIA)d – (AA/AIA)i 
            (AA/AIA)d 
 
where  (AA/AIA)d = ratio of AA to acid-insoluble ash in the diet 
and  (AA/AIA)i = ratio of AA to acid-insoluble ash in the ileal digesta 
 
Levene’s test was used to test for homogeneity of variance and the Kolmogorov-Smirnov test was used to 
test for normal distribution of the data. All data of equal variance and normal distribution were analysed by 
ANOVA using the GLM procedure of SAS Enterprise guide 3.0. The Bonferroni (Dunn) t-test was used to 
test for differences between treatment means where the treatment effect was found to be significant. The 
probability level was set at 5%. 
 
4.4. Results and discussion 
 
Results 
 
The results of AND coefficients for the entire experimental period are presented in Table 4.3. Due to the 
absence of some results, it was difficult to evaluate the effects of the different treatments at day 21. The lack 
of results was mainly because the amount ileum contents collected for those treatments were too small, and 
it further decreased with the drying process. At days 28 and 35 there were no significant (P>0.05) differences 
between the different treatments. It can therefore be concluded that no treatments had any beneficial or 
negative effect on AND, when compared to each other. 
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Table 4.3. Apparent Nitrogen digestibility (AND) coefficients (±SE) for 21, 28 and 35 days. 
Period D21 D28 D35 
Treatment N AND N AND N AND 
MOSL1 2 0.803 (0.005) 2 0.797 (0.008) 2 0.829
 (0.006) 
MOSL2  2 0.813 (0.000) 2 0.791 (0.003) 2 0.805 (0.004) 
MOSL3  2 0.725 (0.045) 2 0.741 (0.008) 2 0.823 (0.009) 
APL1 2 - 2 0.726 (0.004) 2 0.776 (0.010) 
APL2 2 - 2 0.830 (0.000) 2 0.798 (0.000) 
APL3 2 0.770 (0.024) 2 0.796 (0.019) 2 0.755 (0.025) 
MCTL1 2 0.804 (0.044) 2 0.823 (0.000) 2 0.801 (0.000) 
MCTL2 2 - 2 0.734 (0.000) 2 0.737 (0.044) 
MCTL3 2 - 2 0.823 (0.009) 2 0.770 (0.017) 
C- 2 - 2 0.731 (0.000) 2 0.722 (0.002) 
C+  2 - 2 0.781 (0.000) 2 0.721 (0.000) 
P-value 2 0.3446  2 0.0040  2 0.0211  
– Could not be determined. 
C+ = positive control; C- = negative control; MOS = Bio-Mos®; ACP4 = Acid-Pak 4-way®; MCT = Medium chain 
triglycerides; L = levels 
 
The different treatments were compared to the treatments with (positive control) or without (negative control) 
the antibiotic (doxycyclin) supplementation for days 21, 28 and 35. 
 
The AAD at day 21 are presented in Table 4.4. When compared to the negative control, the treatment 
supplemented with MCT (3.4g/kg) have improved AAD for 12 amino acids (ala, thr, ser, val, his, asp, pro, tyr, 
cys, ileu, leu and gly), but had a negative effect (P<0.05) on AAD for five amino acids (arg, glu, lys, met and 
phen). The treatments with Bio-Mos® (0.5g/kg and 1g/kg), Acid-Pak 4-way® (1g/kg and 1.6g/kg) and MCT 
(2.1g/kg) had a negative effect on AAD for glutamic acid and the treatment with Bio-Mos® (1.5g/kg) had a 
negative effect on AAD for three amino acids (his, lys and met). When compared to the positive control, the 
treatment supplemented with MCT (3.4g/kg) have improved AAD for 14 amino acids (ala, thr, ser, val, his, 
asp, lys, pro, tyr, cys, ileu, phen, leu and gly) and had a negative effect on three amino acids (arg, glu and 
met). The treatments with Bio-Mos® (0.5, 1 and 1.5g/kg), Acid-Pak 4-way® (1.6g/kg) and MCT (2.1g/kg) 
improved AAD for two amino acids (ileu and phen), and the treatment with Acid-Pak 4-way® (1g/kg) had a 
negative effect on nine amino acids (thr, ser, val, asp, pro, tyr, ileu, phen and leu). 
 
The AAD at day 28 are presented in Table 4.5. The following significant (P<0.05) differences, between 
treatments, were found. When the treatments were compared to the negative control, the treatment 
supplemented with MCT (2.7g/kg) had a negative effect on AAD only for valine. For the rest of the 
treatments, there were no significant (P>0.05) effects on AAD when compared to the negative control. When 
the treatments were compared to the positive control, the treatment supplemented with Bio-Mos® (1.5g/kg) 
improved AAD (P<0.05) for 13 amino acids (ala, thr, ser, arg, val, his, pro, met, tyr, cys, ileu, leu and gly), the 
treatment with Bio-Mos® (0.5g/kg) improved AAD (P<0.05) for 11 amino acids (ala, thr, ser, arg, val, his, pro, 
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met, tyr, cys and gly). The treatment with Acid-Pak 4-way® (0.4g/kg) improved AAD (P<0.05) for 10 amino 
acids (ala, thr, ser, val, met, tyr, cys, phen, leu and gly). The treatment with Bio-Mos® (1g/kg) improved AAD 
(P<0.05) for six amino acids (ala, val, met, tyr, cys and gly) and the treatment with MCT (3.4g/kg) have also 
improved AAD for six amino acids (thr, arg, met, tyr, cys and gly). The treatment with Acid-Pak 4-way® 
(1.6g/kg) improved AAD (P<0.05) for four amino acids (met, tyr, cys and gly) and the treatment with Acid-Pak 
4-way® (1g/kg) and MCT (2.1g/kg) improved AAD (P<0.05) for three amino acids (met, tyr and cys). The 
treatment supplemented with MCT (2.7g/kg) improved AAD for 11amino acids (ala, thr, ser, arg, val, his, asp, 
lys, pro, ileu and gly), but had a negative effect on the AAD for three amino acids (met, tyr and cys).    
 
The AAD at day 35 are presented in Table 4.6. No treatments had any beneficial or negative effect (P<0.05) 
on AAD, when compared to the negative and positive controls. 
 
Discussion  
 
The most significant effects were seen at days 21 and 28. At day 21, the treatment supplemented with MCT 
(3.4g/kg) had the most significant beneficial effect on AAD, when compared to the negative- and positive 
control, as it increased AAD for the majority of the amino acids. The treatment with Acid-Pak 4-way® (1g/kg) 
had the most significant negative effect on AAD when compared to the positive control. At day 28, the 
treatments with Bio-Mos® (0.5g/kg and 1.5g/kg) and Acid-Pak 4-way® (0.4g/kg) have shown to have the 
most significant beneficial effect on AAD when compared to the positive control. It increased AAD for more 
than half of the 17 amino acids. The treatment supplemented with MCT (2.7g/kg) has shown the most 
significant negative effect on AAD, when compared to the positive control.  
 
4.5 Conclusions 
 
It can be concluded that MCT had the greatest beneficial effect at day 21, although Akiba et al., (1993) found 
no influence on true amino acid availability with MCT inclusion. Bio-Mos® and Acid-Pak 4-way® had the 
more pronounced beneficial effect at day 28. These results agree with Adibmoradi et al., (2006) which found 
that garlic meal indirectly activate the absorptive process, as well as Yang et al., (2007) that observed a 
numerical increase in the nutrient digestibility in the small intestine. Although addition to water is 
recommended for Acid-Pak 4-way, it has also proven that it is possible to be included in the feed. 
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Table 4.4 Mean apparent digestibility coefficients (±SE) for individual amino acids in broiler chickens on a diet supplemented with either Bio-Mos®, Acid-Pak 4-way® 
or MCT at 21 days. 
Treatment 
Amino acid MOSL1 MOSL2 MOSL3 APL1 APL2 APL3 MCTL1 MCTL2 MCTL3 C- C+ P-value 
Anine 0.823 (0.004) bc 0.797 (0.003) bc 0.602 (0.061) c 0.810 (0.055) bc 0.490 b 0.838 (0.021) bc 0.838 (0.039) bc 0.776bc 1.037a 0.851 (0.037) bc 0.661 (0.048) bc <0.0001 
Threonine 0.774 (0.005) bc 0.853 (0.002) bc 0.602 (0.061) bc 0.758 (0.070) bc 0.492 b 0.713 (0.037) bc 0.813 (0.045) bc 0.640bc 1.228 a 0.784 (0.053) bc 0.589 (0.058) c <0.0001 
Serine 0.772 (0.005) bc 0.852(0.002) bc 0.602 (0.061) c 0.780 (0.064) bc 0.494 b 0.800 (0.026) bc 0.819 (0.044) bc 0.650bc 1.253 a 0.814 (0.045) bc 0.612 (0.055) c 0.0002 
Arginine 0.853 (0.003) bc 0.889 (0.002) bc 0.602 (0.061) c 0.745 (0.074) bc 0.497 b 0.912 (0.011) b 0.936 (0.015) b 0.854bc 0.719 a 0.889 (0.027) bc 0.748 (0.036) bc 0.0002 
Glutamic acid 0.896 (0.002) b 0.891 (0.002) b 0.602 (0.061) c 0.844 (0.045) bc 0.492 b 0.887 (0.014) b 0.893 (0.026) b 0.824bc 0.642 a 0.912 (0.022) c 0.822 (0.025) bc <0.0001 
Valine 0.795 (0.004) bc 0.823 (0.002) bc 0.602 (0.061) c 0.762 (0.069) bc 0.489 b 0.821 (0.023) bc 0.825 (0.042) bc 0.690bc 1.241 a 0.833 (0.041) bc 0.586c(0.058) c <0.0001 
Histidine 0.855 (0.003) bc 0.885 (0.002) b 0.602 (0.061) c 0.834 (0.048) bc 0.494 b 0.881 (0.015) b 0.884 (0.028) b 0.831bc 0.952 a 0.897 (0.025) b 0.810 (0.027) bc <0.0001 
Aspartic acid 0.840 (0.003) bc 0.854 (0.002) bc 0.602 (0.061) bc 0.782 (0.063) bc 0.486 b 0.816 (0.024) bc 0.844 (0.038) bc 0.717bc 0.831 a 0.750 (0.061) bc 0.493 (0.071) c <0.0001 
Lysine 0.856 (0.003) bc 0.906 (0.001) b 0.602 (0.061) c 0.815 (0.054) bc 0.495 b 0.872 (0.016) bc 0.891 (0.026) b 0.772bc 0.822 a 0.896 (0.026) b 0.732 (0.038) bc <0.0001 
Proline 0.840 (0.003) bc 0.856 (0.002) bc 0.602 (0.061) c 0.801 (0.058) bc  0.494 b 0.853 (0.019) bc 0.853 (0.035) bc 0.753bc 1.047 a 0.809 (0.047) bc 0.621 (0.053) c <0.0001 
Methionine 0.943 (0.001) b 0.967 (0.000) b 0.602 (0.061) c 0.933 (0.019) b 0.500 b 0.972 (0.004) b 0.969 (0.008) b 0.929b 0.654 a 0.953 (0.011) b 0.801 (0.028) bc <0.0001 
Tyrosine 0.851 (0.003) bc 0.871 (0.002) bc 0.602 (0.061) c 0.812 (0.054) bc 0.500 b 0.881 (0.015) bc 0.890 (0.026) bc 0.754bc 0.926 a 0.870 (0.032) bc 0.628 (0.052) c <0.0001 
Cysteine 0.758 (0.005) bc 0.915 (0.001) bc 0.602 (0.061) bc 0.678 (0.093) bc 0.500 b 0.735 (0.034) bc 0.928 (0.017) bc 0.521c 1.098 a 0.633 (0.090) bc 0.625 (0.053) bc <0.0001 
Isoleucine 0.874 (0.003) bc 0.881 (0.002) bc 0.602 (0.061) bc 0.804 (0.057) bcd 0.494 b 0.846 (0.020) bc 0.892 (0.026) bc 0.766bcd 1.051 a 0.837 (0.040) bcd 0.497 (0.071) d <0.0001 
Phenylalanine 0.912 (0.002) b 0.937 (0.001) b 0.602 (0.061) bc 0.846 (0.044) bcd 0.494 b 0.893 (0.014) bc 0.947 (0.013) b 0.840bcd 0.829 a 0.861 (0.034) bcd 0.587 (0.058) d <0.0001 
Leucine 0.870 (0.003) bc 0.889 (0.002) bc 0.602 (0.061) c 0.829 (0.049) bc 0.494 b 0.884 (0.015) bc 0.891 (0.026) bc 0.803bc 0.918 a 0.868 (0.032) bc 0.665 (0.047) c <0.0001 
Glycine 0.808 (0.004) bc 0.854 (0.002) bc 0.602 (0.061) c 0.778 (0.064) bc 0.988 b 0.777 (0.028) bc 0.849 (0.036) bc 0.783bc 2.004 a 0.846 (0.038) bc 0.735 (0.037) bc <0.0001 
a-d  Means within a row with different superscripts are significantly different. 
C+ = positive control; C- = negative control; MOS = Bio-Mos®; AP = Acid-Pak 4-way®; MCT = Medium chain triglycerides; L = levels 
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Table 4.5 Mean apparent digestibility coefficients (±SE) for individual amino acids in broiler chickens on a diet supplemented with either Bio-Mos®, Acid-Pak 4-way® 
or MCT at 28 days. 
Treatment 
Amino acid MOSL1 MOSL2 MOSL3 APL1 APL2 APL3 MCTL1 MCTL2 MCTL3 C- C+ P-value 
Alanine 0.772 (0.001) bc 0.716 (0.003) c 0.754 (0.007) c 0.811 (0.004) bc 0.943 (0.057) ab 0.854 (0.015) abc 0.428abc 0.372c 0.877 (0.007) abc 0.854 (0.005) abc 0.500a 0.0007 
Threonine 0.676 (0.002) c 0.808 (0.002) abc 0.757 (0.007) bc 0.711 (0.006) bc 0.927 (0.073) ab 0.777 (0.022) abc 0.422abc 0.326c 0.771 (0.013) bc 0.768 (0.009) bc 0.500 a 0.0021 
Serine 0.663 (0.002) c 0.807 (0.002) abc 0.742 (0.007) bc 0.640 (0.007) bc 0.923 (0.077) ab 0.776 (0.023) abc 0.425abc 0.319c 0.806 (0.011) abc 0.822 (0.007) abc 0.500 a 0.0011 
Arginine 0.808 (0.001) bc 0.869 (0.001) abc 0.834 (0.005) bc 0.859 (0.003) abc 0.949 (0.051) ab 0.899 (0.010) abc 0.472ab 0.395c 0.838 (0.009) bc 0.883 (0.004) abc 0.500 a 0.0037 
Glutamic acid 0.909 (0.000) a 0.918 (0.001) a 0.893 (0.003) a 0.940 (0.001) a 0.952 (0.048) a 0.931 (0.007) a 0.459a 0.442a 0.925 (0.004) a 0.920 (0.003) a 0.500 a 0.1659 
Valine 0.780 (0.001) bc 0.791 (0.002) bc 0.787 (0.006) bc 0.811 (0.004) bc 0.940 (0.060) ab 0.848 (0.015) abc 0.426abc 0.374c 0.845 (0.009) abc 0.837 (0.006) ab 0.500 a 0.0045 
Histidine 0.887 (0.001) b 0.906 (0.001) ab 0.887 (0.003) b 0.914 (0.002) ab 0.964 (0.036) ab 0.915 (0.009) ab 0.461ab 0.430b 0.913 (0.005) ab 0.911 (0.003) ab 0.500 a 0.0135 
Aspartic acid 0.729 (0.001) ab 0.791 (0.002) ab 0.718 (0.008) ab 0.797 (0.004) ab 0.903 (0.097) ab 0.758 (0.024) ab 0.383ab 0.327b 0.747 (0.014) ab 0.746 (0.010) ab 0.500 a 0.0240 
Lysine 0.873 (0.001) ab 0.914 (0.001) ab 0.874 (0.004) ab 0.868 (0.003) ab 0.950 (0.049) ab 0.907 (0.009) ab 0.457ab 0.423b 0.895 (0.006) ab 0.905 (0.004) ab 0.500 a 0.0412 
Proline 0.740 (0.001) bc 0.786 (0.002) abc 0.748 (0.007) bc 0.804 (0.004) abc 0.928 (0.072) ab 0.826 (0.018) abc 0.419abc 0.340c 0.819 (0.010) abc 0.808 (0.007) abc 0.500 a 0.0052 
Methionine 0.954 (0.000)  0.944 (0.001)  0.926 (0.002)  0.935 (0.001)  0.969 (0.031)  0.956 (0.004) 0.485 0.458 0.965 (0.002)  0.951 (0.002)  0.500  0.0745 
Tyrosine 0.872 (0.001) 0.859 (0.002)  0.811 (0.005) 0.823 (0.004)  0.925 (0.075)  0.889 (0.011) 0.451 0.418 0.912 (0.005) 0.905 (0.004)  0.500  0.0776 
Cysteine 0.923 (0.000) 0.924 (0.001)  0.828 (0.005)  0.826 (0.003)  0.913 (0.087)  0.911 (0.009)  0.448 0.425 0.912 (0.005)  0.861 (0.005)  0.500  0.1670 
Isoleucine 0.828 (0.001) ab 0.811 (0.002) ab 0.787 (0.006) b 0.814 (0.004) ab 0.935 (0.065) ab 0.873 (0.013) ab 0.438ab 0.402b 0.852 (0.008) ab 0.823 (0.007) ab 0.500 a 0.0159 
Phenylalanine 0.877 (0.001) ab 0.893 (0.001) ab 0.840 (0.004) ab 0.814 (0.004) b 0.944 (0.056) ab 0.902 (0.010) ab 0.451ab 0.426ab 0.869 (0.007) ab 0.867 (0.005) ab 0.500 a 0.0231 
Leucine 0.861 (0.001) ab 0.863 (0.002) ab 0.828 (0.005) b 0.828 (0.003) b 0.942 (0.058) ab 0.899 (0.010) ab 0.445ab 0.415ab 0.888 (0.006) ab 0.885 (0.004) ab 0.500 a 0.0255 
Glycine 0.768c(0.001) c 0.823 (0.002) bc 0.807 (0.005) bc 0.787 (0.004) bc 0.948 (0.052) ab 0.831 (0.017) bc 0.831abc 0.378c 0.834 (0.009) bc 0.827 (0.006) bc 0.500 a 0.0018 
a-c  Means within a row with different superscripts are significantly different. – Could not be determined. 
C+ = positive control; C- = negative control; MOS = Bio-Mos®; AP = Acid-Pak 4-way®; MCT = Medium chain triglycerides; L = levels 
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Table 4.6 Mean apparent digestibility coefficients (±SE) for individual amino acids in broiler chickens on a diet supplemented with either Bio- Mos®, Acid-Pak 4-
way® or MCT at 35 days. 
a-b  Means within a row with different superscripts are significantly different. – Could not be determined. 
C+ = positive control; C- = negative control; MOS = Bio-Mos®; AP = Acid-Pak 4-way®; MCT = Medium chain triglycerides; L = levels 
 
Treatment 
A m i n o  a c i d MOSL1 MOSL2 MOSL3 APL1 APL2 APL3 MCTL1 MCTL2 MCTL3 C- C+ P -v a lu e 
Alanine 0 .873 (0 .001)   0 .792  (0 .003)   0 .804 (0 .007)  0 .827 (0 .005)  0 .883 (0 .117)  0 .773 (0 .030)   0 . 8 3 0 0.793 (0 .034)  0 .800 (0 .014)  0 .781 (0 .002)  0 .825  (0 .001)   0 . 6 4 7 4 
Threonine 0 .820 (0 .002)   0 .843  (0 .002)   0 .812 (0 .007)  0 .791 (0 .007)  0 .905 (0 .095)  0 .763 (0 .031)   0 . 8 4 2 0.742 (0 .042)  0 .749 (0 .018)  0 .701 (0 .002)  0 .755  (0 .001)   0 . 0 6 7 3 
Serine 0 .8 0 3  (0 . 0 02 ) 0 .848  (0 .002)   0 .846 (0 .006)  0 .778 (0 .007)  0 .908 (0 .092)  0 .758 (0 .032)   0 . 8 1 2 0.715 (0 .047)  0 .787 (0 .015)  0 .742 (0 .002)  0 .788  (0 .001)   0 . 0 8 7 7 
Arginine 0 .853  0 .002 ) a b 0 .900  (0 .001)  a b  0 .913 (0.003) a b 0 .874 (0.004) a b 0.954 (0.046) a 0 .892 (0 .014 )  a b 0 . 9 3 0 a b 0.827 (0.028) a 0 .851 (0.011) a b 0 .857 (0.001) a b 0 .834  (0 .001)  a b 0 . 0 1 0 2 
Glutamic acid 0 .941 (0 .001)   0 .919  (0 .001)   0 .916 (0 .003)  0 .929 (0 .002)  0 .942 (0 .058)  0 .899 (0 .013)   0 . 9 2 1 0.840 (0 .026)  0 .886 (0 .008)  0 .887 (0 .001)  0 .896  (0 .001)   0 . 1 3 9 4 
Valine 0 .849 (0 .002)   0 .836  (0 .002)   0 .824 (0 .007)  0 .827 (0 .005)  0 .899 (0 .101)  0 .772 (0 .030)   0 . 8 3 6 0.776 (0 .037)  0 .749 (0 .018)  0 .773 (0 .002)  0 .780  (0 .001)   0 . 2 6 1 2 
Histidine 0 .925 (0 .001)   0 .923  (0 .001)   0 .918 (0 .003)  0 .917 (0 .003)  0 .955 (0 .045)  0 .893 (0 .014)   0 . 9 2 6 0.868 (0 .021)  0 .880 (0 .009)  0 .893 (0 .001)  0 .901 (0 .001)   0 . 1 2 2 3 
Aspartic acid 0 .796 (0 .002)   0 .832  (0 .002)   0 .790 (0 .008)  0 .772 (0 .007)  0 .877 (0 .123)  0 .737 (0 .035)   0 . 7 9 9 0.658 (0 .056)  0 .684 (0 .023)  0 .697 (0 .002)  0 .697  (0 .002)   0 . 1 0 2 3 
Lysine 0 .905 (0 .001)   0 .913  (0 .001)   0 .915 (0 .003)  0 .908 (0 .003)  0 .932 (0 .068)  0 .868 (0 .017)   0 . 8 8 9 0.830 (0 .028)  0 .817 (0 .013)  0 .841 (0 .001)  0.847  (0 .001)   0 . 0 6 7 7 
Proline 0 .847 (0 .002)   0 .840  (0 .002)   0 .821 (0 .007)  0 .824 (0 .006)  0 .901 (0 .099)  0 .791 (0 .027)   0 . 8 5 6 0.727 (0 .045)  0 .771 (0 .016)  0 .776 (0 .002)  0 .778  (0 .001)   0 . 1 8 6 9 
Methionine 0.973( .0000)  a 0 .956  (0 .001)  a b  0 .966 (0.001) a b 0 .965 (0.001) a b 0 .947 (0.053) a b 0 .845 (0 .020)  b 0 . 9 2 6 a b 0.939 (0.010) a b 0 .864 (0.010) a b 0 .911 (0.001) a b 0 .926  (0 .000)  a b 0 . 0 0 8 7 
Tyrosine 0 .894 (0 .001)   0 .884  (0 .002)   0 .861 (0 .005)  0 .937 (0 .002)  0 .922 (0 .078)  0 .838 (0 .021)   0 . 8 9 1 0.808 (0 .031)  0 .845 (0 .011)  0 .868 (0 .001)  0 .842  (0 .001)   0 . 1 6 6 1 
Cysteine 0.915 (0.001) a b 0 .933  (0 .001)  a b  0 .861 (0.005) a b 0 .980 (0 .001)  0 .914  (0 .086) a b 0 .822 (0 .023)   0 . 8 7 7 a b 0.799 (0.033) a b 0 .859 (0.010) a b 0 .765 (0.002) b 0 .826  (0 .001)  a b 0 . 0 1 4 0 
Isoleucine 0 .874 (0 .001)   0 .852  (0 .002)   0 .821 (0 .007)  0 .867 (0 .004)  0 .890 (0 .110)  0 .778 (0 .029)   0 . 8 5 1 0.790 (0 .034)  0 .704 (0 .021)  0 .763 (0 .002)  0 .757  (0 .001)   0 . 0 9 7 4 
Phenylalanine 0 .895 (0 .001)   0 .907  (0 .001)   0 .883 (0 .004)  0 .908 (0 .003)  0 .928 (0 .072)  0 .835 (0 .022)   0 . 8 9 3 0.834 (0 .027)  0 .768 (0 .017)  0 .829 (0 .001)  0 .803  (0 .001)   0 . 0 2 3 3 
Leucine 0 .902 (0 .001)   0 .884  (0 .001)   0 .871 (0 .004)  0 .899 (0 .003)  0 .924 (0 .076)  0 .840 (0 .021)   0 . 8 8 3 0.831 (0 .028)  0 .817 (0 .013)  0 .833 (0 .001)  0 .835  (0 .001)   0 . 2 0 3 1 
Glycine 0 .860 (0 .001)   0 .868  (0 .001)   0 .864 (0 .005)  0 .821 (0 .006)  0 .921(0 .079)  0 .821 (0 .024)   0 . 8 9 0 0.823 (0 .029)  0 .805 (0 .014)  0 .780 (0 .002)  0 .819  (0 .001)   0 . 1 4 2 8 
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Chapter 5 
The effect of addition of Bio-Mos®, Acid-Pak 4-way and MCT 
on growth performance in broilers 
 
5.1. Introduction  
 
In terms of AAD and AND, the addition of Bio-Mos®, Acid-Pak 4-way® and MCT has proven to have some 
beneficial effects. 
 
In this trial Bio-Mos®, MCT and Acid-Pak 4-way® were tested again, but this time to evaluate its potential to 
increase broiler production performance (growth performance and feed efficiency). The studies, as seen in 
Chapter 3 and 4, with Bio-Mos®, MCT and Acid-Pak 4-Way® have shown some positive results and some 
non-significant results. Additional research was therefore needed to determine their effect on broiler 
production performance. The inclusion levels that proved the most effective at the time, in terms of AND and 
AAD, were used. The main production criteria’s were body weight (BW), body weight gain (BWG), feed 
intake (FI) and feed conversion ratio (FCR) (Whitehead, 2002). 
  
5.2 Materials and methods 
 
Nine hundred day-old Cobb 500 broiler chicks (as-hatched) were placed in thirty floor pens, each pen 
containing thirty birds. The experimental units/pens were allocated at random to five experimental treatments 
with six replicates per treatment. The birds were vaccinated at day-old against Newcastle disease and 
Infectious bronchitis. The environmental temperature within the house was 30°C for the first day and was 
then decreased by 0.5°C every second day to 20°C. Continuous light (24L:0D) was provided for the duration 
of the trail. Birds were offered ad libitum access to feed and water. The experiment had a completely 
randomised design with main effect of dietary treatment. 
 
The three experimental trials were approved by the University of Stellenbosch Animal Ethics Committee.  
 
5.3 Experimental design 
 
A control starter diet and control finisher diet were formulated by the EFG Broiler Nutrition Optimizer Program 
(Winfeed 2 Feed Formulator). A detailed list of the ingredients used in the experimental diet and the 
formulated nutrient composition of the diets are presented in Table 5.1. 
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Table 5.1 Composition of starter and finisher diets for broiler chickens based on as fed basis (g/kg). 
Ingredient Starter Finisher 
Maize 549.85 708.73 
Soybean 46 270 251.34 
Soybean full fat 125.23  
Choline chloride 60% 0.67 0.53 
DL-methionine 2.36 1.34 
L-threonine 0.03  
L-lysine HCL 7.68 1.46 
Limestone 21.69 18.13 
Salt 4.03 4.07 
Monocalcium phosphate 11.78 7.41 
Sodium bicarbonate 4.08 4.18 
Vitamin E  0.40 
Vit + min premix 0.50 1.3 
Calculated nutrient content (*)   
AMEn (MJ/kg) 12.49 12.68 
Crude protein (%) 22.00 17.50 
Lysine (%) 1.27 0.95 
Methionine (%) 0.56 0.41 
Methionine + Cystine (%) 0.93 0.72 
Threonine (%) 0.88 0.69 
Tryptophan (%) 0.27 0.20 
Arginine (%) 1.51 1.12 
Isoleucine (%) 1.00 0.79 
Leucine (%) 1.95 1.65 
Histidine (%) 0.62 0.50 
Phenylalanine + tyrosine (%) 1.88 1.51 
Valine (%) 1.05 0.84 
Calcium  1.10 0.90 
Total Phosphorous 0.67 0.54 
(*) Amino acids expressed on a digestible basis. AMEn: Nitrogen corrected Apparent Metabolisable Energy 
 
The starter and finisher diets were fed as a mash. Bio-Mos®, MCT and Acid-Pak 4-way® were included at 
3.0g/kg, 4,2g/kg and 1.6g/kg respectively. A summary of the dietary treatments are presented in Table 5.2. 
The starter diet was provided from day one to day thirteen and the finisher diet from day fourteen to the end 
of the trial at day 35. Birds were weighed (per pen) on arrival and on days seven, 14, 21, 28, 35. Food intake 
per pen was measured at days seven, 14, 21, 28 and 35 and mortality was recorded daily. Feed conversion 
ratio (FCR) is equal to gram feed, divided by the weight (g) gained. Body weight gain (BWG) is equal to the 
total weight (g) gained during the entire experimental trial. 
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Table 5.2.  Dietary treatments used throughout the trial. 
Treatment Description
A Control - 
B Control + 
C Control + Bio-Mos®    
D Control + MCT 
E Control + Acid-Pak 4-way® 
 
Data were tested for homogeneity of variance using Levene’s test and for normal distribution using the 
Kolmogorov-Smirnov test. All data of equal variance and normal distribution were analysed by ANOVA using 
the GLM procedure of SAS Enterprise guide 3.0 (Waldroup et al., 2003; Angel et al., 2005).The Bonferroni 
(Dunn) t-test was used to test differences between treatment means when the treatment effect was found to 
be significant. The probability level was set at 5%. 
 
5.4. Results and discussion 
 
The treatment means for body weight (BW) for the entire experimental period are presented in Table 5.3. No 
treatments had any significant effects on BW (P=0.05) for days 0-7, 8-14, 15-21, 22-28 and 29-35 of the 
experimental period.  
 
Table 5.3. Mean bodyweight (BW) (g/bird) (±SE) on the dietary treatments for the periods 0-7d, 8-14d, 15-
21d, 22-28d and 29-35d, respectively.  
Period  0-7d 8-14d 15-21d 22-28d 29-35d
Treatment N BW  BW BW BW  BW
C- 5 169.33 (6.018)  435.39 (13.850)  822.87 (20.494)  1377.31 (34.289)  1845.91 (39.011) ab  
C+ 5 173.08 (6.018)  438.79 (13.850)  839.07 (20.494)  1395.56 (34.289)  1870.11 (39.011) ab  
MOS 5 169.95 (6.018)  433.08 (13.850)  822.38 (20.494)  1384.74 (34.289)  1870.85 (39.011) ab  
MCT 5 171.76 (6.018)  435.04 (13.850)  811.07 (20.494)  1346.25 (34.289)  1814.19 (39.011) b  
AP 5 174.39 (6.018)  443.27 (13.850)  851.78 (20.494)  1413.46 (34.289)  1911.00 (39.011) a  
P-value  0.910  0.953  0.329  0.401  0.188  
 a-b  Means within a column with different superscripts are significantly different. 
C+ = positive control; C- = negative control; MOS = Bio-Mos®; AP = Acid-Pak 4-way®; MCT = Medium chain 
triglycerides 
 
The treatment means for body weight gain (BWG) for the entire experimental period are presented in Table 
5.4. There were no significant (P≥0.05) differences between treatments for days 0-7, 8-14, 22-28 and 29-35 
of the experimental period. At days 15-21, the treatment supplemented with Acid-Pak 4-way® had a 
significantly (P=0.017) higher BWG, when compared to the negative control, as well as the treatments 
supplemented with Bio-Mos® and MCT. The treatment with MCT performed poorer, in terms of BWG, when 
compared to the positive control.   
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Table 5.4. Mean bodyweight gain (BWG) (g/bird/period) (±SE) of the dietary treatments for the periods 0-7d, 
8-14d, 15-21d, 22-28d and 29-35d, respectively. 
Period  0-7d 8-14d 15-21d 22-28d 29-35d
Treatment N BWG  BWG BWG BWG  BWG
C- 5 124.46 (5892)  266.06 (9.204)  387.48 (9.164) bc  554.44 (19.712)  468.60 (20.221)  
C+ 5 129.94 (5892)  265.71 (9.204)  400.29 (9.164) ab  556.48 (19.712)  474.55 (20.221)  
MOS 5 125.97 (5892)  263.13 (9.204)  389.29 (9.164) bc  562.36 (19.712)  486.11 (20.221)  
MCT 5 127.67 (5892)  263.28 (9.204)  376.03 (9.164) c  535.18 (19.712)  467.94 (20.221)  
AP 5 132.03 (5892)  268.88 (9.204)  408.52 (9.164) a  561.68 (19.712)  497.54 (20.221)  
P-Value  0.714  0.970  0.017  0.646  0.544  
a-c  Means within a column with different superscripts are significantly different. 
C+ = positive control; C- = negative control; MOS = Bio-Mos®; AP = Acid-Pak 4-way®; MCT = Medium chain 
triglycerides 
 
The treatment means for feed intake (FI) for the entire experimental period are presented in Table 5.5. There 
were no significant (P≥0.05) differences between treatments for the entire experimental period.  
  
Table 5.5 Mean feed intake (FI) (g/bird/period) (±SE) of the dietary treatments for the periods 0-7d, 8-14d, 
15-21d, 22-28d and 29-35d, respectively. 
a-c  Means within a column with different superscripts are significantly different.  
C+ = positive control; C- = negative control; MOS = Bio-Mos®; AP = Acid-Pak 4-way®; MCT = Medium chain 
triglycerides 
 
The treatment means for feed conversion ratio (FCR) for the entire experimental period are presented in 
Table 5.6. There were no significant (P≥0.05) differences between treatments for days the entire 
experimental period.  
 
 
 
 
 
 
 
 
Period  0-7d 8-14d 15-21d 22-28d 29-35d
Treatment N FI  FI FI FI  FI
C- 5 204.78 (10.892) ab  429.09 (19.194) ab  1305.30 (83.623) ab  1046.61 (24.127)  1042.14  (22.680)  
C+ 5 204.87 (10.892) ab  410.60 (19.194) b  1354.06 (83.623) a  1050.92 (24.127)  1033.81 (22.680)  
MOS 5 196.22 (10.892) ab  418.79 (19.194) ab  1143.15 (83.623) c  1045.27 (24.127)  1052.98 (22.680)  
MCT 5 187.54 (10.892) b  454.85 (19.194) a  1165.96 (83.623) bc  1036.80 (24.127)  1047.99 (22.680)  
AP 5 214.66 (10.892) a  436.70 (19.194) ab  1316.03 (83.623) ab  1078.41 (24.127)  1059.92 (22.680)  
P-value  0.168  0.210  0.060  0.500  0.814  
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Table 5.6 Feed conversion ratio (FCR) (±SE) of the dietary treatments for the periods 0-7d, 8-14d, 15-21d, 
22-28d and 29-35d, respectively. 
Period  0-7d 8-14d 15-21d 22-28d 29-35d 
Treatment N FCR  FCR FCR FCR FCR  
C- 5 1.65 (0.062) a  1.62 (0.074) ab  3.37 (0.227) 1.90 (0.054) 2.23 (0.079)  
C+ 5 1.58 (0.063) ab  1.55 (0.074) b  3.39 (0.227) 1.90 (0.054) 2.19 (0.079)  
MOS 5 1.56 (0.063) ab  1.59 (0.074) ab  2.94 (0.227) 1.86 (0.054) 2.17 (0.079)  
MCT 5 1.47 (0.063) b  1.73 (0.074) a  3.10 (0.227) 1.94 (0.054) 2.25 (0.079)  
AP 5 1.63 (0.063) a  1.62 (0.074) ab  3.22 (0.227) 1.92 (0.054) 2.14 (0.079)  
P-value  0.059  0.207  0.267  0.663  0.690  
a-b  Means within a column with different superscripts are significantly different. 
C+ = positive control; C- = negative control; MOS = Bio-Mos®; AP = Acid-Pak 4-way®; MCT = Medium chain 
triglycerides 
 
None of the treatments had any significant effect on BW, but Zulkifli et al. (2006) found opposing results 
which proved that Acid-Pak 4-way® improved BW. In terms of BWG, Acid-Pak 4-way® had a higher BWG, 
when compared to the negative control, Bio-Mos® and MCT. Sun et al. (2005) also found that the effects of 
Acid-Pak 4-way® on BWG was comparable with the effects of antibiotic supplementation. In terms of FI and 
FCR, no treatments proved to have an effect.  
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Chapter 6 
General Conclusion 
 
The search for effective alternatives to antibiotic feed additives has intensified as a result of the ban on 
antibiotic growth promoters in Europe. Several strategies are currently available that can have significant 
impacts on poultry production. The basic mechanisms that explain the beneficial effects of these strategies 
are often clearly different from those that explain the effects of antimicrobial growth promoters. There is 
limited data to support the efficacy of many of the AGP alternatives that are commercially available. Often 
field trials are conducted without the inclusion of positive and negative controls; variation is almost 
impossible to rule out. In addition, the exact mode of action is frequently not known and research to clarify 
these factors is expensive.  
 
The primary objective of this thesis was to evaluate whether alternative feed additives, such as fresh garlic, 
Bio-Mos®, Acid-Pak 4-way® and MCT, may improve N and AA digestibility and thus performance of a 
commercial diet. In both of the digestibility trials, none of the treatments (garlic, Bio-Mos®, Acid-Pak 4-way® 
and MCT), improved AND. In the first trial, neither garlic nor Bio-Mos® showed any improvement in AAD at 
any determination period (day 21, 28 or 35). In the second trial, all three treatments (Bio-Mos®, Acid-Pak 4-
way® and MCT) showed some improvement in terms of AAD. Acid-Pak 4-way® proved to have some 
beneficial effects in terms of BWG.   
 
It can be concluded that Bio-Mos®, Acid-Pak 4-way®, as well as MCT can be a possible alternatives to 
antibiotic supplementation. These three treatments did not necessary prove to be more effective than 
antibiotics, but are definitely competitive alternatives. There were more prominent effects with the production 
performance trial with Acid-Pak 4-way®. The lack of response, especially seen with AAD, could be the result 
of no real health challenge for the birds; for example facilities were too clean or the correct diet composition 
was formulated. 
 
Whether or not we, as an industry, are convinced that there is a scientific case for the withdrawal of 
subtherapeutic antibiotics, it is clear that the consumer has the last say. It is therefore important that 
alternative strategies for improving poultry production are identified. The use of alternatives to AGP’s will not 
provide a single solution to AGP removal from animal feed.  One of the most important lessons to be learned 
is that AGP removal necessitates improved general husbandry and management, hygiene and health status 
are essential for minimising the losses from in-feed AGP removal.  
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